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During embryogenesis, mesenchymal progenitor cells exhibit hyaluronan-dependent 
pericellular matrices as a major component of the extracellular matrix.  As connective tissues form 
by cellular condensations, there is a loss of cell-associated hyaluronan to facilitate cell-to-cell 
adhesion. The goal of this dissertation is to gain insight into how hyaluronan-associated 
components of the extracellular/pericellular matrix participate in directing differentiation fates of 
mesenchymal cells. This work began with attempts to isolate and study a primary mesenchymal 
progenitor population from adult bovine articular cartilage and progressed to the use of the 
adipocyte-favoring mesenchymal progenitor cell line, 3T3-L1.  A particle exclusion assay revealed 
that 3T3-L1 mesenchymal cells exhibited large hyaluronan-dependent pericellular matrices that 
were displaced by small hyaluronan fragments consisting of 6-8 disaccharides, suggesting 
retention of the matrix by a cell surface receptor.  These pericellular matrices were enhanced with 
the addition of exogenous aggrecan (prepared from bovine articular cartilage).  However, 3T3-L1 
cells lost the ability to synthesize or retain a hyaluronan-dependent pericellular matrix during 
adipogenesis.  We observed a reduction in mRNA and protein expression of CD44, the hyaluronan 
receptor that anchors the pericellular matrix to the cell surface, during adipogenesis, in addition to 
a reduction in mRNA expression of Has2 and Vcan. These reductions in pericellular matrix 
components are likely responsible for the loss of detectable pericellular matrix by 3T3-L1 
adipocytes. The importance of CD44’s role in pericellular matrix retention was further supported 
when pericellular matrices could not be formed by 3T3-L1 adipocytes even when exogenous 
hyaluronan and aggrecan were supplied.  Hyaluronan was visualized by staining with a binding 
protein (HABP) and fluorescent microscopy.   Mesenchymal cells exhibited bright cell surface 
HABP staining whereas adipocytes stained only weakly.  However, when the adipocytes were 
permeabilized with 0.5% Triton-X, hyaluronan was revealed between the lipid droplets of these 
cells suggesting receptor-mediated endocytosis. When hyaluronan synthesis was blocked with 4-
methylumbelliferone, adipogenesis of 3T3-L1 cells was significantly inhibited. Additionally, 
exogenous aggrecan added to the culture medium during the adipogenic differentiation protocol 
significantly inhibited adipogenesis. Collectively, these data suggest that 3T3-L1 adipogenesis is 
dependent upon the temporal regulation of hyaluronan.    
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CHAPTER 1: INTRODUCTION 
 
 
1. Overall Summary 
 
A new cell type isolated from articular cartilage has been described as having progenitor 
characteristics.  This discovery offers new hope for cartilage regeneration therapies that could 
potentially replace or enhance current cartilage repair techniques that can at times produce 
structurally inadequate cartilage. The ability to quickly efflux the vital stain Hoechst 33342 is 
commonly used to isolate these (chondro)progenitor cells, collectively called a “side population”.  
Differential adhesion to fibronectin has been used to enrich the side population and some 
investigators have used putative mesenchymal progenitor cell markers CD105, CD166, and Notch-
1 to isolate these chondroprogenitor cells.  However, the use of these markers to isolate the side 
population from articular cartilage is still debated.  
 
There are several proposed markers for the identification of progenitor cells but induced 
differentiation into different cell types is a very convincing demonstration of multipotency. Three 
common lineages to demonstrate multipotency of mesenchymal progenitor cells are chondrocytes, 
osteocytes, and adipocytes. Three well characterized cell lines were chosen to serve as positive 
controls for each of these differentiation pathways, C3H10T1/2 for chondrogenic, MG-63 for 
osteogenic, and 3T3-L1 for adipogenic differentiation. While cells isolated from articular cartilage 
induced to differentiate into osteocytes is not particularly impressive, those same cells induced to 
become adipocytes would provide more conclusive evidence of multipotency, therefore the 
primary focus was to establish a working adipogenesis protocol with 3T3-L1 cells.  In addition to 
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differentiation experiments, these same three cell lines were used to verify that our lab could 
identify Hoechst 33342 efflux by microscopic observation.  
 
Out of the three cell lines tested for Hoechst 33342 efflux potential via microscopic 
observation, it was evident that 3T3-L1 cells had the highest Hoechst 33342 efflux capability 
which was surprising since this cell line is considered unipotent to pre-adipocytes. The 3T3-L1 
cell line is a well-established model for studying adipogenesis but could potentially become an 
even greater asset for researching mesenchymal cell differentiation if multipotency could be 
established.  Even though this was not a primary goal of this dissertation, some preliminary 
experiments demonstrated that after induction with chondrogenic medium in micromass culture, 
3T3-L1 cells showed chondrogenic potential with positive alcian blue staining and increased 
expression of chondrogenic markers, aggrecan and hyaluronan synthase-2.  Much more research 
is needed to confirm the use of 3T3-L1 cells as a potential model for chondrogenesis but these 
initial experiments are promising.   
 
For my original goal, I was able to successfully isolate a side population in bovine articular 
cartilage cells using flow cytometry to detect increased Hoechst 33342 efflux but not in sufficient 
numbers to make downstream differentiation experiments feasible.  Researchers have 
circumvented low side population numbers by expanding their populations, but this is undesirable 
since primary chondrocytes maintained in monoculture have been shown to dedifferentiate, 
developing morphology changes that resemble mesenchymal cells.  I attempted to enrich the side 
population by selecting cells able to adhere to fibronectin, a documented characteristic of 
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progenitor cells, but was unable to detect a difference in Hoechst 33342 efflux by microscopic 
observation in fibronectin adherent (progenitor) vs non-adherent cells. However, while additional 
attempts were made to increase side population cell numbers, I worked to establish an adipogenesis 
protocol with 3T3-L1 cells. 
 
 During adipogenic differentiation of 3T3-L1 cells, the culture medium became notably 
more viscous. This interesting observation was pursued to find that the increased viscosity was 
partly attributed to increased hyaluronan in the culture medium as noted by previous researchers. 
However, there appeared to be a clear gap in knowledge as to how hyaluronan and hyaluronan-
associated components of the extracellular matrix contributed to directing differentiation of these 
3T3-L1 mesenchymal cells into adipocytes. This led us to investigate changes in the pericellular 
matrix and its components during adipogenesis while my attempts to increase the side population 
cell numbers for my original goal went without success.  
 
This study found that mesenchymal 3T3-L1 cells exhibit large hyaluronan-dependent 
pericellular matrices, but during adipogenesis, 3T3-L1 cells lost the ability to retain a pericellular 
matrix even when supplemented with exogenous hyaluronan and aggrecan. This could partly be 
explained by the decrease in the hyaluronan receptor, CD44, which anchors the pericellular matrix 
to the cell surface. In addition, hyaluronan was visualized mainly on the surface of mesenchymal 
3T3-L1 cells whereas the majority of hyaluronan was discovered inside adipocyte 3T3-L1 cells, 
between lipid droplets. These findings reveal that hyaluronan is removed from the surface of 3T3-
L1 cells as they transition from mesenchymal progenitor cells to adipocytes, either by release from 
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the cell surface or by internalization or likely both.  However, whether the reduction of cell surface 
hyaluronan is required for adipogenesis to occur or is merely a by-product of the differentiation 
process remained unknown. Our lab and many others have used 4-MU as an inhibitor of 
hyaluronan biosynthesis. This study found that inhibition of hyaluronan synthesis with 4-MU 
treatment throughout the adipogenic protocol significantly decreased adipogenesis of 3T3-L1 
cells. Others have reported that treatment with hyaluronidase to degrade synthesized hyaluronan 
during adipogenesis also significantly inhibited 3T3-L1 adipogenesis. These findings suggests the 
presence of hyaluronan is a requirement for 3T3-L1 adipogenesis to occur.  
 
Our lab has shown the addition of exogenous aggrecan to chondrocytes blocks endocytosis 
of CD44 and hyaluronan. Treatment of 3T3-L1 mesenchymal cells with exogenous aggrecan 
caused the pericellular matrix to swell as aggrecan molecules fully decorated hyaluronan. This 
study found that the addition of exogenous aggrecan to the culture media during the adipogenic 
protocol led to a significant decrease in adipogenesis of 3T3-L1 cells. The mechanism of this 
inhibition could be due to blocked hyaluronan endocytosis or blocked release from the cell-surface. 
These findings indicate that not only the presence of hyaluronan is required for 3T3-L1 
adipogenesis, but that hyaluronan molecules bound to the cell surface must not be sterically 
hindered and available for endocytosis or interaction with other molecules. The major findings of 
this study reveal that not only is the presence of hyaluronan required but also that hyaluronan must 
then be removed from the cell surface for 3T3-L1 adipogenesis to occur suggesting that 3T3-L1 




2. Articular Cartilage 
2.1.  Structure and function 
Articular cartilage is a smooth, viscoelastic, connective tissue that lines the surface of 
articulating bones of diarthrodial joints to provide a low-friction, load-bearing surface that allows 
joint movement. Articular cartilage offers protection to subchondral bone from mechanical stress 
by redistributing weight and resisting compression. This ability is afforded by the unique 
properties of the extracellular matrix (ECM) which comprises over 90% of the total mass of 
articular cartilage. The ECM is composed of proteoglycans, collagen fibrils, and a variety of other 
macromolecules [1].  Aggrecan is the predominate proteoglycan in the ECM of articular cartilage 
and attracts water molecules which allows for shock absorption and compression resistance 
because of its negative charge [2]. Type II collagen is the most abundant type of collagen in 
articular cartilage and provides tensile strength and shape for the tissue as well as a framework to 
resist the swelling pressure of aggrecan [3]. Collagens IX and XI are important in the fibrillary 
network; mutations in these genes result in chondrodysplasia with early onset osteoarthritis [4]. In 
addition, collagen-binding receptors, such as integrins and the discoidin domain receptor-2 are 
essential for mediating cell-matrix interactions in articular cartilage [5]. The remaining percentage 
of articular cartilage’s total mass (estimates range between 1% and 10%) is made up of its cellular 
component, chondrocytes being the main cell type found in this tissue [6-8].  
 
Articular cartilage is arranged into horizontal, laminar zones that are characterized mainly 
by chondrocyte shape and collagen orientation. The layer adjacent to the subchondral bone consists 
of hypertrophic chondrocytes and a calcified matrix called the calcified zone. The deep zone, next 
to the calcified zone, is characterized by a special distribution of collagen fibrils that form vertical 
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columns around rapidly proliferating chondrocytes [9, 10]. The middle zone is described as having 
collagen fibers that twist into circles or intersect into a bent crosshatch network around round 
chondrocytes [11]. Flat, nearly inactive chondrocytes with collagen fibers parallel to the surface 
are found in the superficial zone next to the joint space [12]. The arrangement and organization of 
articular cartilage reflects its purpose. The superficial zone provides a smooth, nearly friction free 
surface while deeper zones are responsible for shock absorption and compression resistance.  
 
In addition to horizontal zones, the ECM can be further divided into circumferential zones 
based on proximity to chondrocytes. They are, from farthest to closest to a resident chondrocyte, 
called the interterritorial, territorial, and pericellular matrices.  While they contain many of the 
same molecular components, there are some distinct differences in the structure and composition 
between them. The interterritorial matrix is characterized as having a higher concentration of 
keratan sulfate rich proteoglycans while more chondroitin sulfate rich proteoglycans are found in 
the territorial matrix [1, 13].  The pericellular matrix is generally characterized as having higher 
concentrations of fibronectin, proteoglycans, and type VI collagen, when compared to the rest of 
the ECM [14], but its underlying scaffold is comprised of hyaluronan, a non-sulfated 
polysaccharide [15]. Through hyaluronan, the pericellular matrix gains another of its defining 
characteristics which is direct anchorage to the cell surface via hyaluronan binding receptors, such 
as CD44 [16]. Hyaluronan will be discussed further in section 3. Because of its intimate association 
with chondrocytes, the pericellular matrix influences many biochemical or biophysical signals they 
receive and therefore, plays an important role in regulating cell biosynthesis [17]. For example, 
aggrecan, which is synthesized inside chondrocytes and then secreted, is converted into a form 
with a higher binding affinity for hyaluronan outside the cell in the matrix [18].  
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2.2.  Articular cartilage cells 
Chondrocytes, the main cell type in articular cartilage, either singly or in groups, establish 
a specialized microenvironment, the pericellular matrix, that together are called the “chondron” 
and can be thought of as a functional unit of articular cartilage [19]. Unlike the majority of cells 
found in other tissues, most chondrocytes exist without direct cell-cell contact and have a hypoxic 
metabolism [20]. Because articular cartilage is an avascular tissue, chondrocytes rely on diffusion 
from the articular surface for their nutrients and metabolites [13]. Chondrocytes are responsible 
for synthesis, degradation, and regulation of all components of the ECM, including large volumes 
of collagens, glycoproteins, and proteoglycans.  They also maintain homeostasis of the articular 
cartilage matrix by sustaining a balance between catabolic and anabolic events [8, 21]. The number 
of chondrocytes in articular cartilage remains relatively unchanged throughout life, although their 
distribution differs. The superficial zone of articular cartilage shows a decrease of chondrocytes 
while deeper zones show an increase [22]. This redistribution likely leads to decreased superficial 
ECM maintenance and a decrease in lubrication of the articular cartilage surface, resulting in 
decreased proteoglycan aggregates causing increased tissue stiffness and likelihood for injury.  
 
 
Historically, chondrocytes were thought to be the only cell type in articular cartilage, 
however, a population of cells recently found in articular cartilage has been shown to have 
progenitor characteristics such as a high colony formation capacity, mesenchymal stem cell 
markers, and acquire a chondrogenic phenotype  after several passages [23, 24]. These cells, 
termed chondro-progenitors, have been isolated from bovine, mouse, and even human articular 
cartilage [24-26]. Both healthy and osteoarthritic articular cartilage contain cells with putative 
mesenchymal progenitor markers such as CD105, CD166, and Notch-1 but it is heavily 
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emphasized that widely accepted markers may not be applicable for detection of progenitors in 
articular cartilage [27, 28]. These cells also respond to transforming growth factors (TGFs) and 
enhance synthesis of articular cartilage markers, aggrecan and collagen II [25, 26]. Unlike MSCs 
isolated from bone marrow, these chondroprogenitor cells can maintain chondrocyte phenotype 
without calcification or expression of hypertrophic traits in 3D culture systems [29, 30]. In other 
tissues, stem/progenitor cells provide a renewable source of cells capable of replacing damaged 
differentiated cells. This discovery opens the possibility of targeting a resident progenitor cell 
population within articular cartilage for not only repair, but regeneration of damaged cartilage.  
 
2.3.  Osteoarthritis 
2.3.1.  Definition and characterization 
Due to its avascular nature and low mitotic activity, articular cartilage displays little 
capacity for self-repair [9]. Any lesions or minor injuries occurring in articular cartilage are 
unlikely to heal and will frequently lead to degenerative joint diseases such as osteoarthritis (OA) 
[31]. OA does not affect just the articular cartilage, but rather the whole diarthrodial joint. This is 
a complex organ consisting of several key components, including articular cartilage, subchondral 
bone, and synovial membrane lining the inner layer of the fibrous joint capsule. OA results in 
osteophyte formation, subchondral bone remodeling, and synovial membrane inflammation which 
may further articular cartilage tissue degradation. Osteoarthritic change starts with the loss of the 
superficial layer of articular cartilage and as the disease progresses, deeper zones are damaged and 
lost [10]. The surface of OA cartilage appears frayed and jagged when compared to healthy 
cartilage. The shearing of cartilage signals a local inflammatory response (without neutrophils or 
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macrophages) that releases proinflammatory cytokines like interleukin (IL)-1 and tumor necrosis 
factor (TNF)-α. These catabolic cytokines are needed at low levels for homeostasis and are 
balanced by anabolic, inhibitory cytokines like those in the bone morphogenetic protein (BMP) 
family. OA disease is thought to progress when disruption of this balance is tipped in favor of the 
catabolic cytokines [32]. 
 
Catabolic cytokines induce expression of proteinases that breakdown components of the 
ECM. The main aggrecanase upregulated in OA cartilage is the disintegrin and metalloproteinase 
with thrombospondin motifs (ADAMTS)-4 [33]. ADAMTS-4 first cleaves aggrecan in the 
superficial layer and immediately surrounding chondrocytes. This produces a halo around 
chondrocytes when stained with safranin-O and is considered one of the first histological signs of 
OA disease. The main collagenase upregulated in OA cartilage is the matrix metalloproteinase 
(MMP)-13 which cleaves several types of collagen [34]. Collagen cleavage is considered a late 
response in OA and is not reversible, whereas cleavage of aggrecan is considered an early response 
and is reversible by de novo synthesis of aggrecan by resident chondrocytes [35].  
 
Cartilage defects are traditionally categorized by the four grades of the Outerbridge 
classification system in which grade I is defined as swollen and softened cartilage, grade II contains 
fragmentation or fissures 1.27 cm or less. If the defect exceeds this size, it is classified as grade III 
until the injury reaches the subchondral bone in which case it is then classified as grade IV [36]. 
However, since OA affects the whole joint and not just the articular cartilage, a different 
classification system is needed to define its severity and progression.  
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Today, the most widely used classification tool for the radiographic diagnosis of OA is the 
five grade scheme developed by Kellgren and Lawrence (KL) in 1957 [37]. The KL classification 
system distinguishes grades using mainly joint space width and osteophyte formation. Osteophytes 
are fibrocartilage capped bony outgrowths that originate from the periosteum of cortical bone [38]. 
Grade 0 is healthy articular cartilage with no signs of joint space narrowing (JSN) or osteophyte 
formation. Grade 1 has doubtful JSN with possible osteophyte formation while grade 2 has definite 
osteophyte formation with possible JSN. Grade 3 joints are defined as having moderate 
osteophytes, definite JSN, and some bone-end deformity. The most severe, grade 4, is 
characterized by large osteophytes, marked JSN, and definite bone-end deformity. While this 
system has been criticized for not being entirely appropriate for monitoring the progression of OA, 
it still remains the most widely used for assessing the initial severity of OA when patients present 
with pain [39].   
 
2.3.2.  Economic burden 
The most common cause of chronic disability in older adults is OA, which is considered a 
‘wear and tear’ disease defined as the progressive degeneration of articular cartilage [40]. 
Clinically, OA is characterized by joint pain, limitation of movement, popping sounds from the 
affected joint, stiffening after periods of immobilization, and different degrees of inflammation 
[41]. The main risk factors for developing OA are, age (elderly people), gender (women more than 
men), prior joint injuries, misalignment of the joint, abnormal biomechanics, genetic 
predisposition and obesity [42]. OA causes a significant amount of pain and loss of mobility for 
approximately 12.1% of the entire US population, over 35 million people, and is a significant 
economic burden [43]. In a study completed with 2011 data, OA patients were found to have a 
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greater comorbidity burden and spend nearly four times as much on overall healthcare costs per 
year compared to patients without OA, $8,644 compared to $2,273 [44]. Additionally, OA patients 
were found to lose almost twice as much time from work due to pain or recovery, which raised 
their indirect costs even more [45]. Patients with OA incur greater direct and indirect medical costs 
in addition to decreased quality of life and work productivity compared to those without OA. 
 
2.3.3  Current treatments 
Current treatment for focal articular cartilage defects focus on reducing pain while surgical 
options aim to regenerate or replace damaged articular cartilage. Symptoms of early OA, such as 
pain, stiffness, and swelling are usually treated non-surgically with oral/topical pharmaceuticals, 
physical therapy, and/or life-style changes such as increased activity and weight loss. When these 
are no longer effective, more invasive procedures are available to alleviate symptoms. 
Intraarticular injections of corticosteroids or hyaluronan have been shown beneficial for reliving 
acute flare-ups but are not recommended for long term use as they have also been shown to 
eventually accelerate degradation of articular cartilage [46-48]. In the not so distant past, when 
OA had become well developed and there was no more hope for re-establishing a healthy cartilage 
surface, prosthetic joint replacement was the only solution for restoring mobility to the affected 
joint. However, in recent years, several alternative surgical methods have been developed that aim 
to regenerate articular cartilage. The three main techniques that are currently employed are 
microfracture, osteochondral grafts, and autologous chondrocyte implantation.  
 
Steadman et al. (2010) describes microfracture as a regenerative technique in which 
mesenchymal stem cells are recruited from subchondral bone and bone marrow. This method is 
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recommended for grade III and some IV cartilage defects that do not include loss of the underlying 
bone and are surrounded by healthy cartilage. A 2-4 mm perforation is made in the subchondral 
bone to allow migration of bone marrow progenitor cells to the open space. A fibrin clot is formed 
that remodels into fibrocartilaginous tissue over a period of 12-16 months [49]. Fibrocartilage is 
inferior to hyaline cartilage and lacks mechanical properties that allow it to withstand mechanical 
stress over time [50]. In addition, this microfracture technique requires a very long post-operatory 
period where weight bearing is restricted until mostly healed. Some reports have shown that 
although patients initially feel significantly improved, the affected joint functionality is not 
maintained for more than a year and efficacy depends on other factors such as patient age, 
compliance with post-operative rehabilitation, and size of initial damage.  
 
Osteochondral grafts involve transplantation of full-thickness cartilage samples, including 
subchondral bone, from either the patient (autograft) or a cadaver (allograft). Allografts allow for 
a larger area of cartilage to be replaced but come with the increased risk of disease transmission 
while autografts are considered safer but limit the size of the defect that can be repaired and come 
with complications at the donor site [51]. Osteochondral grafts have a much shorter post-operative 
period than microfracture, about 6 weeks, and an even longer efficacy period of about 10 years 
[52]. However, a shortage of available healthy tissue makes this option for only relatively small 
defects.  
 
Autologous chondrocyte implantation (ACI) was developed as a two stage process, 
involving an arthroscopic and surgical step, to treat large cartilage defects [53]. Peterson et al. 
(2000) reports that ACI is generally recommended for patients with grade III and IV cartilage 
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defects, with preferably intact subchondral bone, and for whom other treatments have not been 
successful. Normal articular cartilage is harvested from a non-weight bearing area and then 
expanded in vitro before being applied to the damaged area during a second surgery [54]. Articular 
cartilage is not a cellularly dense tissue, therefore the number of cells harvested is very limited. 
During expansion, chondrocytes do not maintain their phenotype well and tend to de-differentiate 
in culture. De-differentiated chondrocytes express fewer markers for hyaline cartilage, collagen II 
and aggrecan, and more markers for fibrocartilage, collagen I and versican. However, studies have 
shown that two years after implantation, markers for both hyaline and fibrocartilage can be 
detected [54, 55]. Currently, the only Food and Drug Administration (FDA) approved method of 
tissue engineering in the United States is the transplantation of in vitro expanded autologous 
chondrocytes commercialized under the name of Carticel® [56]. This procedure still requires a 
long post-operative period of limited weight-bearing but good results have been reported, however 
there is still room for improvement.       
     
The most appropriate cell source for cartilage tissue engineering is one that is either 
abundant or can be easily expanded and which can produce large amounts of ECM components 
specific to hyaline cartilage without de-differentiation (or with re-differentiation after in vitro 
expansion of cell numbers). Mesenchymal stem cells (MSCs) can be isolated from numerous 
tissues and can differentiate into several musculoskeletal lineages, including chondrocytes [57, 
58]. While there isn’t a perfect solution, the use of MSCs promises significant opportunities for 
cartilage engineering, but their characterization is still ill-defined and there are currently no 
established guidelines for MSCs to be used clinically [57]. Additionally, a subpopulation of MSCs 
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isolated from articular cartilage, chondroprogenitor cells, are a current focus of research efforts to 




3.  Adipose tissue 
 
Adipose tissue is a metabolically dynamic organ that is classified into two types; white and 
brown [59]. Brown adipose tissue is a specialized thermogenic tissue that converts chemical 
energy into heat and is protective against metabolic disease. Rodents and other small mammals 
have copious brown adipose tissue deposits but larger mammals often lose most of their brown 
adipose tissue after infancy [60]. White adipose tissue is the most abundant type of adipose tissue 
in large mammals and is defined by its long term energy storage in the form of triacylglycerides 
in unilocular lipid droplets [61]. While not thermogenic, white adipose tissue does provide thermal 
insulation and efficient energy storage, as well as having extensive distribution in the body to offer 
mechanical protection and lower friction for muscle bundles and organs to move without 
compromising their functional integrity [60].  
 
The predominant cell type in adipose tissue is the adipocyte and there are three types found 
in mammals; white, brown, and beige (brite). They differ in origin, morphology, number of 
mitochondria, and thermogenic gene expression [62]. White adipocytes are mainly found in white 
adipose tissue and are of mesenchymal origin. They have a unilocular lipid droplet, few 
mitochondria, and a low oxidative rate [63]. Brown adipocytes comprise brown adipose tissue and 
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are derived from myogenic precursor cells [64]. They have a smaller diameter than white 
adipocytes, abundant mitochondria, contain multilocular lipid droplets, and dissipate stored energy 
in the form of heat [65]. There is a second thermogenic type of adipocyte called beige or brite 
which is a “brown-like” adipocyte with multilocular morphology. Studies have suggested that 
these cells can arise from de novo differentiation of mesenchymal/adipocyte progenitor cells or 
from transconversion of white adipocytes but underlying molecular mechanisms of this lineage 
remain unknown [66].  
 
3.1.  Cell model for adipogenesis study 
 The study of pre-adipocyte differentiation in vivo is difficult because adipose tissue in adult 
mammals is roughly only one third adipocytes with the remaining two-thirds a combination of pre-
adipocytes, fibroblasts, blood vessels, and nerve tissue [67].  In addition, little work has been 
completed with primary cultures because distinguishing between fibroblasts and pre-adipocytes is 
challenging due to their similar morphology, however, significant progress has been made in the 
last few years separating these two cell types with flow cytometry [68]. Also, since pre-adipocytes 
constitute such a small portion of adipose tissue, large amounts are required to isolate a relevant 
amount for experimental purposes. The limited life span of primary cultures also contributes to the 
difficulty in studying adipogenesis ex vivo. Therefore, pre-adipocyte differentiation has been 
primarily studied using in vitro cell models, most notably, the so called “unipotent” pre-adipocyte 
3T3-L1 cell line [69, 70].  
 
 The 3T3-L1 cell line was derived from the fibroblastic NIH 3T3 cell line which are from 
disaggregated Swiss 3T3 BALB/c mouse embryos [71].  The parental NIH 3T3 cell line is highly 
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susceptible to spontaneous transformations that allow it to adapt to a variety of culture conditions 
[72-75]. The adipogenic ability of 3T3-L1 cells has been demonstrated numerous times and our 
findings here were repeated with different cell stocks and passage numbers which suggest our 
results are likely due to the inherent characteristics of the 3T3-L1 cells instead of the pre-neoplastic 
nature of their parental NIH 3T3 cell line. The 3T3-L1 cell line is one of the most well-
characterized and reliable models for studying the conversion of pre-adipocytes to adipocytes [76]. 
When injected into mice, 3T3-L1 cells differentiate and form fat pads that are indistinguishable 
from normal adipose tissue [77]. Additionally, in culture, differentiated 3T3-L1 cells possess most 
of the ultrastructural characteristics of adipocytes from animal tissue with the formation and 
appearance of developing lipid droplets mimicking live adipose tissue [71, 78]. Because of this, 
3T3-L1 cells have been extensively studied to establish the underlying molecular mechanisms of 
adipogenesis. 
 
3.2.  Adipogenesis of 3T3-L1 cells 
Differentiation of pre-adipocytes to adipocytes involves a comprehensive network of 
transcription factors that are responsible for expression of key proteins to induce mature adipocyte 
formation [79]. The process of adipogenesis also involves significant changes in cell morphology, 
induction of insulin sensitivity and changes in secretory capacity of cells. Once 3T3-L1 cells reach 
confluence, the cell-cell contact inhibits replication and induces very early markers of adipocyte 
differentiation, including lipoprotein lipase and collagen VI [80, 81].  Confluent 3T3-L1 cells can 
be induced to undergo adipogenesis simultaneously by a defined adipogenic medium that includes 
a combination of a glucocorticoid, an agent that elevates intracellular cAMP levels, and insulin, 
all in the presence of fetal bovine serum [82]. Dexamethasone is used to stimulate the 
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glucocorticoid pathway and methylisobutylxanthine, a cAMP-phosphodiesterase inhibitor, is used 
to stimulate the cAMP-dependent protein kinase pathway while insulin acts by stimulating cells to 
take up glucose, which is then stored in the form of triglycerides [83].  
 
About 24 hours after treatment with an adipogenic medium, 3T3-L1 cells undergo a post-
confluent mitosis, completing at least one round of DNA replication and cell division. By the 
second day, the cells complete mitosis and enter growth arrest again, committing the cells to 
adipogenic differentiation [84]. This mitosis step is believed to be necessary to unwind DNA so 
that transcription factors can gain access to regulatory response elements present in genes involved 
in modulating the mature adipocyte phenotype [85].  CCAAT/enhancer binding proteins (C/EBP) 
β and δ are the first transcription factors induced after exposure to the adipogenic inducers. C/EBPβ 
and δ activity mediate the expression of transcriptions factors C/EBPα and peroxisome 
proliferator-activated receptor (PPAR) γ.  Expression of either C/EBPα or PPARγ alone leads to 
the expression of the other (they serve as a positive feed-back loop for each other), suggesting that, 
at the final stages of adipogenesis, both C/EBPα and PPARγ function in a cooperative manner to 
induce adipocyte specific genes that establish the mature adipocyte phenotype [86]. The terminal 
differentiation stage of adipocytes is characterized by induction of genes that are important for 
insulin action, lipid synthesis, and transport. Many of these genes have promoters that contain 
regulatory elements for PPARγ, like the fatty acid binding protein (FABP)-4, which is a lipid 
chaperone and considered a marker for late adipogenesis [87].  PPARγ is capable of promoting 
adipogenesis in C/EBPα deficient cells but C/EBPα is not able to promote adipogenesis in PPARγ 
deficient cells. Therefore, even though these two transcription factors mutually induce the 
expression of each other, only PPARγ is considered the master regulator of adipogenesis [88].   
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The commitment of pre-adipocytes to adipocytes involves various signaling pathways that 
influence key regulators of adipogenesis, like C/EBPα and PPARγ. Adipogenic differentiation is 
governed by sequential activation of a number of other transcription factors that function 
downstream of signaling pathways leading to adipocyte establishment. One signaling pathway that 
affects adipocyte differentiation is initiated by transforming growth factor (TGF)-β which has been 
shown to inhibit adipogenesis in vitro [89]. While the exact mechanism of TGF-β adipogenic 
inhibition is still unknown, studies have shown that inhibition occurs through a Smad3 dependent 
pathway in which Smad3, activated by TGF-β, binds to C/EBPβ and C/EBPδ and inhibits their 
transcriptional activity [89, 90]. This in turns leads to decreased PPARγ transcription, which is the 
main regulator for adipogenesis. 
 
3.3.  Extracellular matrix during adipogenesis  
An understanding of the control of cell shape, growth and differentiation requires 
consideration of interactions between the cell and its environment. Although the transcriptional 
regulation of adipogenesis has been extensively studied, the role of the extracellular matrix (ECM) 
microenvironment on the regulation of adipogenesis has not been fully elucidated. However, there 
is increasing evidence that the ECM strongly influences adipogenesis and that extracellular 
macromolecules can regulate cell behavior directly to the cell interior through receptor-mediated 
interactions. In a study of human mesenchymal stem cells (MSC), ECM for adipogenesis and 
osteogenesis were designed to mimic the stages of differentiation of the two cell types, which was 
found to regulate the expression of transcription factors effectively controlling the balance of 




The ECM maintains a very dynamic equilibrium between the synthesis and degradation of 
ECM proteins for maintenance and remodeling. Matrix metalloproteases (MMPs) contribute to 
ECM remodeling by degrading ECM and basement membrane components for adipocyte 
differentiation and expansion [92]. Although comprehensive MMP substrate discovery screens 
have just begun, it is generally stated that every component of the ECM can be cleaved by one or 
more of the 23 members of the MMP family [93-95]. Several studies have demonstrated that 
activity of MMPs are required for adipogenesis to occur and that their inhibition decreases 
adipocyte differentiation [92, 96]. For example, upon addition of adipogenic inducers, the tissue 
inhibitor of MMP (TIMP)-3 expression is strongly reduced and is maintained at low levels 
throughout adipogenesis. In addition, overexpression of TIMP-3 in 3T3-L1 cells inhibits adipocyte 
differentiation through repressed C/EPBβ expression [97]. This suggests TIMP-3 down regulation 
is essential for adipocyte differentiation and is specifically involved in the regulation of early 
adipogenic induction.  
 
The ECM components associated with the cytoskeleton via receptors, like integrins, play 
an important role in the morphological change during adipogenesis. Integrins are essential to link 
ECM components, like collagen, to the cell surface. Crosstalk between ECM components and 
transcription factors, including PPARγ, influence adipocyte differentiation [98]. Signaling through 
type I collagen has been suggested to be a key regulatory component during adipogenesis because 
its continued expression decreased expression of PPARγ [99].  
 
The plasma membrane glycoprotein, CD44, is also essential for mediating cell-matrix 
interactions although very little is known about its role in adipogenesis. CD44 is the principal cell 
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surface receptor for hyaluronan, an integral part of the ECM that is discussed in the next section. 
CD44 appears to exhibit a capacity for cell signaling induced by alterations in CD44-HA 
interactions [100, 101]. In addition, the cytoplasmic domain of CD44 has been shown to interact 
with cytoskeletal adaptor proteins ezrin, radixin, and moesin (ERM) [102] as well as ankyrin [103, 
104]. These interactions may suggest a role for CD44 in the cell shape which is drastically altered 
as the pre-adipocyte changes from a fibroblast form to the rounded cell shape distinctive in mature 
adipocytes. Transient knockdown of membrane-cytoskeleton linker proteins ezrin, radixin, and 
moesin (ERM) caused disassembly of actin fiber and focal adhesions which decreased cell stiffness 
resulting in inhibited adipogenesis in human MSCs [105]. Several studies have described an 
increase in cell stiffness with adipocyte differentiation due to the increase in mono- and 
polysaturated fatty acids in the lipid monolayer surrounding newly formed lipid droplets [106, 
107].  Additionally, a decrease in actin and tubulin expression is an early event in adipocyte 
differentiation that precedes overt changes in morphology and the expression of adipocyte specific 
genes. These changes in cell shape reflect a distinct process in differentiation and are not the result 
of accumulated lipid stores [108]. The drastic morphological changes observed during adipocyte 
differentiation occur even when triglyceride accumulation is blocked [109]. But whether CD44 









4.  Hyaluronan 
 
Hyaluronan was first purified from the vitreous humor of bovine eyes by Karl Meyer in 
1934 [110]. In the 1950s, Meyer and colleagues determined that hyaluronan was a linear 
polysaccharide composed of repeating units of N-acetylglucosamine and D-glucuronic acid. This 
disaccharide moiety is repeated thousands of times generating a molecule with a molecular mass 
ranging from 0.5 to 20 million Daltons or more [111]. Hyaluronan has several names which reflect 
the properties of the molecule under various conditions. When first isolated, hyaluronan behaved 
like a mild acid and was therefore named “hyaluronic acid” [110]. Under physiological conditions, 
hyaluronan existed as an electrolyte and associated with cations, often as a sodium salt, which 
prompted the name sodium hyaluronate. The name was later amended to just hyaluronate in 
reference to its salt form or hyaluronan to encompass all forms of the molecule and that it is 
included in the glycosaminoglycan family [112].  
 
Hyaluronan is not branched, it does not contain any sulfate groups and it is not covalently 
linked to a proteoglycan protein core [113]. This makes hyaluronan an atypical glycosaminoglycan 
with a very simple chemical composition. Despite this, hyaluronan fulfills several distinct 
molecular functions that contribute not only to the structural and physiological characteristics of 
tissues, but also to the mediation of cell behaviors during morphogenesis, tissue remodeling, 
inflammation and disease [114, 115]. Hyaluronan is extremely hydrophilic and attracts large 
amounts of water to provide hydration and lubrication to various tissues. Through its interaction 
with proteoglycans and link proteins, hyaluronan organizes and maintains the structural integrity 
of extracellular and pericellular matrices. As a signaling molecule, hyaluronan interacts with a 
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variety of cell surface receptors and hyaluronan-binding proteins to activate intracellular events to 
mediate cell functions [113, 114]. Even though its concentration and binding partners vary, 
hyaluronan is ubiquitously found in the ECM of all vertebrate tissues and is evolutionarily 
conserved across mammalian species which further suggests its biological importance [116]. 
 
4.1.  Hyaluronan synthesis and degradation 
Unlike other glycosaminoglycans that are synthesized in the Golgi apparatus, hyaluronan 
is synthesized at the inner face of the plasma membrane by the integral membrane 
glycosyltransferase, hyaluronan synthase (HAS) [117, 118]. There are three eukaryotic isoforms 
that have been identified that are responsible for all hyaluronan synthesis in mammalian species, 
HAS1, HAS2, and HAS3 and they all share significant amino acid homology across different 
species [119]. Each HAS contains two distinct membrane domains, a cytoplasmic loop containing 
the catalytic site and the binding sites for the two UDP-sugar precursors [120]. Hyaluronan is 
polymerized as HAS alternatively adds UDP-N-acetylglucosamine and UDP-glucuronic acid 
monomers to the reducing end of the growing polymer. As polymerization occurs, the non-
reducing end of the chain is translocated through the plasma membrane where it can be released 
into the ECM or retained at the cell surface [121]. A Pore Translocation Model has been proposed 
to explain how hyaluronan reaches the outside of the cell in which the growing disaccharide chain 
is translocated through the HAS enzyme itself to the exterior of the cell [122].  The exact 
mechanism by which hyaluronan synthesis is terminated remains unknown but is partly 




The three individual HAS isoforms also produce hyaluronan of differing sizes [123]. HAS1 
and HAS2 are able to produce higher molecular weight hyaluronan while HAS3 produces 
relatively low molecular weight hyaluronan [124]. Other factors can alter the size of hyaluronan 
such as hyaluronidases, alterations to the UDP sugar pool, or the action of oxygen radicals which 
can all can result in fragments of short oligosaccharides that can trigger inflammation or MMP 
activation [125-128]. Hyaluronan chain size is critical in many cellular process including some 
pathophysiological conditions. Examples include; angiogenesis, wound repair, proliferation and 
migration, induction of inflammatory genes, and differentiation [129-133]. When native 
hyaluronan is displaced by short oligosaccharides, the pericellular matrix is reduced in size [16] 
and catabolic factors are activated in articular chondrocytes [101]. Native hyaluronan displaced by 
oligosaccharides significantly decreases proliferation and migration of vascular smooth muscle 
cells [134]. In addition, high molecular weight hyaluronan was shown necessary for normal cardiac 
morphogenesis in mice [135]. 
 
4-Methylumbelliferone (4-MU) specifically inhibits HAS activity at the post-
transcriptional level and results in a significant decrease in both hyaluronan synthesis and 
extracellular formation. The mechanism of 4-MU inhibition involves the addition of glucuronide 
to 4-MU by exogenous UDP-glucuronyl transferase (UGT) that transfers glucuronic acid to 4-MU 
from UDP-glucuronic acid. This results in a depletion of UDP-glucuronic acid, one of the essential 
precursors for hyaluronan synthesis [136].  
 
As mentioned previously, hyaluronidases can alter the size of hyaluronan. Six 
hyaluronidase (HYAL) genes have been identified in humans with HYAL-1 and HYAL-2 being 
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the major players in most tissues [137, 138]. In some cells, HYAL-2 can associate with cells via a 
glycosylphosphatidyl-inositol anchor [139, 140]. HYAL-2 has also been shown to bind CD44 at 
the chondrocyte plasma membrane [139]. The activity of HYAL-2 associated with CD44 could be 
detected at pH 4.8 and only weak hyaluronidase activity was detected at 6.8 [141]. Nevertheless, 
this would allow HYAL-2 to be internalized along with CD44 to low pH intracellular vesicles. 
Hyaluronan endocytosis via CD44 to low pH intracellular vesicles participates in hyaluronan 
turnover [142]. Most internalized hyaluronan is destined for catabolism in the lysosome [143].  
HYAL-2 is active under acidic conditions generally in lysosomes, however at least one study has 
found HYAL-2 to have activity at near neutral pH only when CD44 is also present [144]. 
Extracellular activity of HYAL-2 is still highly debatable and more research needs to be completed 
but this would provide for extracellular hyaluronan degradation and promote internalization and 
remodeling of the ECM. Experimentally, Streptomyces hyaluronidase is the most commonly used 
hyaluronidase for research because it specifically and exclusively degrades hyaluronan [145]. 
 
4.2.  Hyaluronan receptors 
Hyaluronan interacts with cells through cell surface receptors for its structural role in the 
ECM, to initiate signaling cascades or to be internalized. Described hyaluronan receptors include; 
CD44, Receptor for Hyaluronan-Mediated Motility (RHAMM), Intracellular Adhesion Molecule 
(ICAM)-1, Hyaluronan Receptor for Endocytosis (HARE), and Lymphatic Vessel Endothelial 
Hyaluronan Receptor (LYVE-1).  CD44 is the primary and most studied hyaluronan receptor in 
articular cartilage. CD44 was found to be associated with insulin resistance in adipose tissue but 
its importance during adipogenesis remains largely unknown [146]. CD44 is a single pass 
transmembrane receptor that binds to hyaluronan and plays a primary role in the assembly and 
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maintenance of the pericellular matrix by chondrocytes [147]. In addition to hyaluronan binding, 
CD44 also participates in cell signaling [148], tumor invasion/metastasis [149], and hyaluronan 
endocytosis [150]. The cytoplasmic domain of CD44 interacts with cytoskeleton linker proteins 
ankyrin and ERM (as mentioned previously). ERM proteins crosslink the actin cytoskeleton to 
CD44 and are important in the regulation of cell migration and cell shape, while the interaction 
between CD44 and ankyrin was found necessary for the binding of hyaluronan and retention of 
the pericellular matrix [151, 152].   
 
Hyaluronidase-sensitive pericellular matrices or “coats” have been observed on 
mesenchymal cells isolated from hyaluronan-enriched regions of the developing embryo [153]. 
Due to collapse of these coats during aldehyde fixation, the particle exclusion assay [154] has 
become an important method for visualization of the hydrated coats [155] (Figure 1).   
 
One hyaluronan molecule is able to bind multiple CD44 receptors which increases the 
likelihood of internalization. The CD44 receptors that assist with hyaluronan endocytosis associate 
with lipid rafts which are cholesterol and sphingolipid rich domains in the plasma membrane. This 
association with lipid rafts is necessary for hyaluronan endocytosis but not for binding between 
CD44 and hyaluronan [156]. Internalization of hyaluronan through CD44 mediated endocytosis 
has been shown to require acylation of the cytoplasmic tail [156]. There are many variants of CD44 
due to alternative splicing of variable exons and post-translational modification which might afford 




In both melanoma cells [157] and fibroblasts [158], hyaluronan was able to be internalized 
via CD44 mediated mechanisms but also micropinocytosis that is independent of CD44. However, 
hyaluronan internalization in chondrocytes appears to be strictly CD44 dependent [150]. Work 
with keratinocytes and chondrocytes suggests CD44 mediated hyaluronan internalization is not 
associated with clathrin-coated vesicles, caveolae, or pinocytosis-which suggest a non-classical 
mode of uptake regulated by alternative mechanisms [147, 159]. However, when hyaluronan-
bound CD44 binds to TGF-β type I receptor in human kidney epithelial cells, both are transported 
to lipid rafts and associate with caveolin-1, which is a cholesterol binding protein that is required 
for the formation of caveolae and subsequent clathrin independent endocytosis [160, 161]. 
Adipocytes harbor more cholesterol than any other tissue and have an abundance of caveolae for 
constant trafficking between the plasma membrane and lipid droplets [162]. Even though various 
caveolae/raft pathways largely by-pass fusion with endosomes and lysosomes [163], Choi et al. 
found that mouse fibroblasts, mouse neurons, and human neuroblastoma cells all utilize caveolae-
mediated endocytosis to transport a particular ECM protein to lysosomes for degradation [164]. 
With the extensive remodeling of the ECM, pre-adipocytes undergoing adipogenesis must possess 
a mechanism for degradation and endocytosis of hyaluronan, particularly hyaluronan present in 
the pericellular matrix. This could serve as a mechanism for CD44 mediated ECM turnover during 
adipogenesis.  
   
4.3.  Hyaladherins 
In addition to cell surface receptors, several other proteins bind hyaluronan such as fibrin, 
fibronectin, and a family of proteoglycans which are all collectively called hyaluronan binding 
proteins (HABPs) or hyaladherins [165]. Hyaladherins can be classified based on the binding motif 
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that is used to bind hyaluronan. The cell surface receptor RHAMM binds hyaluronan with a 
B(X7)B sequence where B is a basic residue and the Xs contain at least one basic amino acid but 
the rest can be any other non-acidic amino acids [166]. A second hyaluronan binding motif, called 
the link module, consist of ~100 amino acids that bind to hyaluronan when folded into the correct 
tertiary structure [167]. CD44, versican, and aggrecan all use this link module to bind hyaluronan 
[168]. Both aggrecan and versican are proteoglycans that consist of a core protein decorated with 
sulfated glycosaminoglycans (Figure 2). Hyaladherins generally interact with a small number of 
sugar repeats of hyaluronan so a single chain of high molecular weight hyaluronan can 
theoretically accommodate over 1,000 protein molecules, which explains why many signaling 
responses induced by hyaluronan/protein interactions are heavily dependent on hyaluronan 
molecular weight  [169, 170]. 
 
The first specific hyaladherin discovered was the cartilage proteoglycan, aggrecan [171]. 
This large aggregating chondroitin sulfate proteoglycan was so named because of its high affinity 
for hyaluronan, allowing more than 100 molecules to noncovalently bind to a single chain of 
hyaluronan giving the appearance of a bottle brush. This bond is strengthened further with the 
presence of link protein, a small glycoprotein that also demonstrates strong, specific binding to 
hyaluronan [172, 173]. Similar to aggrecan is versican, which is a proteoglycan synthesized by 
fibroblasts and also aggregates on hyaluronan molecules with a link protein [174]. The repulsion 
between the highly charged chondroitin sulfates in these proteoglycans can have important effects 
on the material properties and permeability of the matrix. Proteoglycans allow the hyaluronan 
chain to remain extended which increases the osmotic swelling of the pericellular matrix which 
directly contributes to compressive stiffness in a tissue [175]. When excess proteoglycan is added, 
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the pore size of the pericellular matrix is decreased but the overall size of the pericellular matrix 
is increased [176, 177].  
 
4.4.  The use of hyaladherins fragments to detect hyaluronan.  
In the past, hyaluronan was quantified by isolating it from other polysaccharides and then 
determining the uronic acid concentration by a colometric assay [178]. It was discovered later that 
hyaluronan could be tightly and specifically bound by a hyaluronan binding protein (HABP) 
composed of a portion of aggrecan as well as the link protein isolated from bovine cartilage [172, 
173, 179]. The addition of a detectable tag on HABP led to the development of new methods for 
specific quantification and visualization of hyaluronan such as a sandwich ELISA-like assay 
(Figure 3A) [180] and immunohistochemistry-like fluorescence assay (Figure 3B) [181].  
 
4.5.  Hyaluronan during adipogenesis 
Hyaluronan was first identified in the culture medium of 3T3-L1 cells undergoing 
adipogenesis in 1991 by Calvo et al. [182]. They observed that as adipogenesis progresses, the 
culture medium became noticeably more viscous. In addition, a high molecular weight 
proteoglycan that contributed to the increased viscosity was also described [182] and later 
identified as versican [183]. This increase in hyaluronan found in the media was partially explained 
by a brief spike in HAS-2 expression during mid-adipogenesis but was also accompanied by a 
similar spike in HYAL-2 expression [184]. When hyaluronan was degraded with Streptomyces 
hyaluronidase or synthesis was blocked with 4-MU, adipogenesis of 3T3-L1 cells was significantly 




All these results indicate a possible role for these ECM molecules during adipogenesis and 
open the field for more thorough study in 3T3-L1 cell differentiation. A thorough understanding 
of the differentiation process would allow for manipulation of adipocyte cell number and control 
of certain diseases (non-insulin dependent diabetes mellitus, hypertension, immune dysfunction, 
certain types of cancer [186]. The study of molecular mechanisms of adipocyte development may 
suggest important patterns for comparison to other developmental systems which may provide 
understanding of the physiology of animal and human development.  
 
 





5.  SPECIFIC AIMS 
 
While the overall goal of this dissertation was to gain insight into how hyaluronan and its 
associated components act in directing differentiation of mesenchymal cells, there was a 
substantial shift in the approach used to achieve that goal. Three specific aims are presented here. 
The first specific aim describes the original, abandoned approach in which primary mesenchymal 
cells were to be isolated from bovine articular cartilage. Even though this aim was not achieved it 
is included here because work performed attempting to accomplish this aim was paramount in 
shifting to the approach outlined in the last two specific aims in which a cell line is used to 
investigate the effects of hyaluronan and its components on mesenchymal cell differentiation 
 
5.1. Isolate a progenitor side population from bovine articular cartilage. 
Several alternative surgical methods are under development to regenerate articular 
cartilage that has been lost or damaged during osteoarthritis disease progression. 
Chondroprogenitor cells, isolated from articular cartilage, could provide a cellular source for 
articular cartilage repair.  Based on other preliminary studies, the goal of this aim is to determine 
whether a side population of progenitor cells can be obtained from adult bovine articular cartilage 





5.2.  Investigate the hyaluronan-dependent pericellular matrix of 3T3-L1 mesenchymal cells 
and 3T3-L1 adipocytes.    
Like many tissues, adipose tissue is regulated by the physiological interaction between 
cells and a variety of extracellular matrix components. Previous studies have shown that the 
pericellular assembly of fibronectin dictates cytoskeletal and extracellular matrix organization 
which affects 3T3-L1 conversion from mesenchymal cells to adipocytes [187] and that modulation 
of pericellular collagen was found necessary for adipogenesis [188]. In mesenchymal to 
chondrocyte differentiation, modulation of hyaluronan dependent pericellular matrices is required 
for chondrogenesis to occur [153] however little is known about pericellular matrix changes during 
adipogenesis.  The goal of this aim is to test the hypothesis that 3T3-L1 mesenchymal cells have 
a hyaluronan-dependent pericellular matrix and it is modulated during the course of adipogenesis.   
 
5.3.  Investigate the role of hyaluronan during adipogenesis of 3T3-L1. 
The maintenance and differentiation of stem cells are intimately mediated by hyaluronan 
and its interactions with proteins. Hyaluronan has been reported to facilitate differentiation of 
mesenchymal cells to chondrocytes, fibroblasts, and keratinocytes [189].  Previous studies have 
implicated a functional role for hyaluronan during 3T3-L1 adipogenesis [182, 184, 185].  The goal 
of this aim is to test the hypothesis that hyaluronan plays an essential role during 3T3-L1 









Figure 1.  The classical particle exclusion assay to reveal hydrated pericellular matrix. The 
pericellular matrix assembled by cells is composed largely of water and hard to visualize with 
traditional staining methods. Adding small inert particles, like formalin fixed equine erythrocytes 
(red blood cells-RBC), which settle down on the tissue culture plastic and around the living cell, 









Figure 2.  Structure of link protein, aggrecan, and versican: three extracellular matrix 
hyaladherins.  The N-terminal globular domain (G1) consists of a signal peptide, two hyaluronan-
binding repeats (tandem repeats) and an immunoglobulin-like motif.  The G1 domain of all three 
molecules binds to hyaluronan mediated by the two tandem repeats.  Link protein is essential just 
the G1 domain (also called the link module).  Only aggrecan contains a second globular domain 
(G2) that consists of two tandem repeats.  Aggrecan and versican have protein cores (represented 
by the entire green line) of differing amino acid sequence and a C-terminal globular domain 
(G3).  This glycosaminoglycan attachment domain between the G2 and G3 domains of aggrecan 
is substituted with keratan sulfate and chondroitin sulfate. For versican, the glycosaminoglycan 
attachment domain between the G1 and G3 domains is substituted with chondroitin sulfate 
only.  The G3 domain consists of a carbohydrate recognition domain and epidermal growth factor-






















Figure 3. HABP is used for quantifying hyaluronan in an ELISA-like assay and visualizing 
cell-associated hyaluronan. In the ELISA-like assay, chondroitenase-treated purified 
proteoglycan (from articular cartilage) is coated to high affinity binding ELISA plates to serve as 
the capture reagent. Hyaluronan (HA) is then incubated with the capture reagent and allowed to 
bind. The detection reagent is biotinylated HABP-B (purple oval-“HABP” with peach “B”) 
followed by the addition of streptavidin conjugated to horseradish peroxidase (blue diamond-
“Strep” with yellow “HRP”) (A). Cell associated hyaluronan (HA) is visualized with biotinylated 
HABP as well. Surface HA is detected in cells cultured and fixed in chamber slides and incubated 
with HABP-b (purple oval-“HABP” with peach “b”). Streptavidin (blue diamond-“SAV”) 
conjugated to Alexa-Fluor 488 (green oval-“AF488”) binds to the biotin linked to HABP for 





CHAPTER 2: MATERIALS AND METHODS 
 
 
1. Cell culture 
 
1.1.  Primary bovine articular cartilage cell isolation and cell culture 
Cells from bovine articular cartilage were isolated using the previously described method 
[128]. Articular cartilage was removed from the metacarpophalangeal joints of adult steers (18 
months) obtained from a local abattoir [191]. To harvest cells from the superficial layer only, very 
thin slices were removed from the cartilage. Middle/deep layers were harvested together by 
removing the remaining cartilage after the superficial layer had been removed. For most 
experiments, full thickness cartilage was removed in slices. Regardless of originating location, 
after the cartilage was removed, it was rinsed in sterile phosphate buffered saline (PBS; 
AMRESCO, Baltimore, MD) and subjected to sequential digestion with 0.2% pronase (EMD 
Scientific, San Diego, CA) in Dulbecco’s Modified Eagle Medium (DMEM; Mediatech, Herndon, 
VA) containing 10% fetal bovine serum (FBS; Hyclone, South Logan, UT), 1% L-glutamine and 
1% penicillin-streptomycin for 1 hour at 37°C, 5% CO2, followed by 0.0025% collagenase P 
(Roche, Indianapolis, IN) in the same diluent and incubation conditions as pronase digestion 
overnight. The next day, the cell suspension was passed through sterile 100 then 40 μm cell sieves 
to filter out clumps and obtain a single cell suspension, which was then centrifuged at 300 x g for 
5 minutes at room temperature. The cell pellet was suspended in Hoechst medium for both 




Hoechst medium consisted of Hanks’ balanced salt solution (Sigma) supplemented with 
2% FBS and 10 mM HEPES (AMRESCO, Solon, OH). 
 
1.2.  MCF-7 cell culture 
The MCF-7 cell line is a stable epithelioid cell line derived from free-floating passages of 
a primary culture of human breast carcinoma cells [192].  They were a gift to the Knudson lab by 
Dr. Li Yang (East Carolina University, NC). MCF-7 cells were cultured as high density 
monolayers in DMEM containing 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin and 
incubated at 37oC in a 5% CO2 environment. The MCF-7 cells were passaged at confluence using 
0.25% trypsin/2.21 mM EDTA. 
 
1.3.  3T3-L1 cell culture 
The 3T3-L1 cell line is a pre-adipose line derived from the established mouse fibroblast 
3T3 line [71] and was a gift to the Knudson lab by Dr. Philip Pekala (formerly East Carolina 
University, NC) or was purchased from ZenBio, Inc (Durham, NC). 3T3-L1 cells were cultured as 
low density monolayers in DMEM containing 10% FBS, 1% L-glutamine and 1% penicillin-
streptomycin (defined as maintenance media; MM) and incubated at 37oC in a 5% CO2 
environment. The 3T3-L1 cells were passaged at no more than 80% confluence using 0.25% 




1.4.  C3H10T1/2 cell culture 
The C3H10 T1/2 cell line was derived from a C3H mouse embryo [193] and was purchased 
from the American Type Culture Collection (Manassas, VA). C3H10T1/2 cells were cultured as 
monolayers in DMEM containing 10% FBS, 1% L-glutamine and 1% penicillin-streptomycin and 
incubated at 37oC in a 5% CO2 environment. The C3H10T1/2 cells were passaged at confluence 
using 0.25% trypsin/2.21 mM EDTA.    
 
1.5.  MG-63 cell culture 
The human MG-63 cell line was derived from an osteogenic sarcoma [194, 195] and was 
purchased from the American Type Culture Collection (Manassas, VA). MG-63 cells were 
cultured as monolayers in DMEM containing 10% FBS, 1% L-glutamine and 1% penicillin-
streptomycin and incubated at 37oC in a 5% CO2 environment. The MG-63 cells were passaged at 
confluence using 0.25% trypsin/2.21 mM EDTA. 
 
1.6.  Rat chondrosarcoma cell culture 
The rat chondrosarcoma cell line (RCS) is a continuous long-term culture line derived from 
the Swarm rat chondrosarcoma tumor [196, 197]. The RCS cell line in the Knudson laboratories 
was a gift of Dr. James H. Kimura (formerly of Rush University Medical Center) and represented 
an early clone of cells that eventually became known as long-term culture RCS [198]. RCS 
chondrocytes were cultured as high-density monolayers in DMEM containing 10% FBS, 1% L-
glutamine and 1% penicillin-streptomycin, and incubated at 37oC in a 5% CO2 environment. RCS 
cells were passaged at confluence using 0.25% trypsin/2.21 mM EDTA. 
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2.  Characterizational assays 
 
2.1.  Phase contrast microscopy 
Cells were observed using a Nikon TE2000 inverted phase-contrast microscope and images 
were captured digitally in real time using a Retiga 2000R digital camera (QImaging, Surrey, 
British Columbia). 
 
2.2.  Fluorescent microscopy 
Fluorescence was observed with either a Nikon TE2000 inverted microscope using 10, 20, 
or 40x objectives or a Nikon E600 microscope and a 60x oil objectiveequipped with a Y-Fl Epi-
fluorescence attachment (Melville, NY). Images were captured digitally using a Retiga 2000R 
digital camera and processed using NIS Elements BR version 1.30 imaging software (Nikon, 
Lewisville, TX) 
 
2.3.  Particle exclusion assay 
Mesenchymal 3T3-L1 cells were plated at a density of 104 cells per cm2 overnight in 
DMEM containing 10% FBS, 1% L-glutamine, and 1% penicillin-streptomycin then incubated at 
37oC in a 5% CO2 environment. 3T3-L1 cells undergoing adipogenesis were dislodged with 
forceful pipetting of PBS and transferred to a new culture well in DMEM + 10% FBS with 1% L-
glutamine  and  1% penicillin-streptomycin.  The  next  day, the  medium  was replaced with 74 
μl/cm2 suspension of formalin-fixed equine erythrocytes in DMEM containing 10% FBS [147]. 
The cultures were allowed to sit for 10 minutes at room temperature before analyses with phase 
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contrast microscopy. On occasion, 4 μM Calcein AM (Molecular Probes, Eugene, OR) was added 
with the RBC suspension to increase visibility of cells. In these instances, cultures were analyzed 
via fluorescent microscopy in addition to phase contrast microscopy.  
 
2.4.  Oil Red O stain 
Stock solution of 5 mg/ml Oil Red O (Matheson Coleman Bell) in 100% isopropyl alcohol 
was diluted in water to 3 mg/ml and filtered.  Cells were rinsed with PBS and fixed with 3.7% 
paraformaldehyde for 2 min at 4C, rinsed again with PBS and stained with filtered Oil Red O for 
1 hour at room temperature. Wells were rinsed 3 times with water before images were observed 
and recorded via phase contrast microscopy or a Canon PowerShot SX700 HS (Tokyo, Japan). For 
quantification, Oil Red O stain was extracted from cells with 100% ethanol for 10 minutes at room 
temperature with rocking. Absorbance was measured with a 492 nm wavelength on Multiskan 
Ascent plate reader (Thermo Scientific). 
 
2.5.  Alcian blue stain 
Micromass cultures (described in section 7.2) to be stained with alcian blue were rinsed 
with PBS and then fixed with 3.7% paraformaldehyde for 10 minutes at room temperature. 
Cultures were rinsed 3 times with PBS then stained with 1% alcian blue/3%acetic acid (Sigma) in 
deionized water for 30 minutes at room temperature. Wells were rinsed 3 times with water before 
images were recorded via a Canon PowerShot SX700 HS (Tokyo, Japan). For quantification, 
alcian blue stain was extracted from micromass cultures with 4 M guanidine HCl (Sigma) 
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overnight at 4°C with rocking. Absorbance was measured with a 592 nm wavelength Multiskan 
Ascent plate reader (Thermo Scientific) 
 
2.6.  Hoechst 33342 stain and efflux assay  
Cells to be analyzed via flow cytometry were counted and suspended in Hoechst medium 
at 106 cells/ml. Hoechst 33342 (Tocris, Bristol, UK) was added to the cells to obtain a final 
concentration of 5 μg/ml then incubated in a 37°C water bath for 90 minutes, in the dark, with 
frequent agitation. Cells were centrifuged at 375 x g for 6 minutes at 4°C then re-suspended at 106 
cells/ml in fresh, cold Hoechst medium with 2 μg/ml propidium iodide (Sigma) but without and 
with 50 μM verapamil (Sigma) [199]. Cell suspensions were kept on ice and in the dark until 
cytometric analysis could be completed (less than 1 hour).  
 
Cells to be microscopically analyzed for Hoechst efflux were suspended at 106 cells/ml in 
Hoechst medium then incubated with 5 μg/ml Hoechst 33342 for 5 or 20 minutes at 4 or 37°C 
[200]. Cells were centrifuged at 375 x g for 6 minutes and re-suspended fresh, cold Hoechst 
medium then plated at 2.5 x 105 cells/cm2.  Images were recorded by phase contrast and fluorescent 







3.  Flow Cytometry 
Single cell suspensions incubated with Hoechst 33342 and propidium iodide, without and 
with verapamil, were analyzed for the presence of a side population using the FACSVantage cell 
sorter (BD Biosciences) fitted with a UV laser for excitation, 675/20 LP filter for Hoechst Red 
detection, 424/44 BP filter for Hoechst Blue detection and a 640 longpass dichroic mirror for 
separation of the Blue and Red signals. Forward scatter (FSC) vs side scatter (SSC), FSC vs 
propidium iodide Red (FL2-H), and Hoechst Red (FL5-H) vs Hoechst Blue (FL4-H) two 
parameter plots were generated with linear scales. Voltages were adjusted so that all cells were 
visible on the FSC vs SSC and FSC vs FL2-H plots [199]. Events with high side scatter, low 
forward scatter, and high propidium iodide fluorescence were excluded on the Hoechst Red vs 
Hoechst Blue plot because these were likely dead cells or cellular debris. One hundred thousand 
events were analyzed and the side population was gated at the left side of the plot, indicating low 
Hoechst Red and Blue and appearing as a tail off the G1 cluster.  
 
4.  Fibronectin adhesion assay 
 Fibronectin coated plates were prepared by allowing 10 μg/ml fibronectin (Sigma) in PBS 
to dry on sterile, uncoated Corning petri dishes (Becton Dickinson Labware, Franklin Lakes, NJ) 
overnight at 4°C [201, 202]. Coated plates were stored at 4°C if not used immediately.  
 
Bovine articular cartilage primary cells isolated from one metacarpophalangeal joint were 
suspended in 10 mls Hoechst medium. The cell suspension was split into two fibronectin coated 
plates with 5 mls each and incubated for 10 minutes at 37°C with 5% CO2. Non-adhered cells 
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(called Bovine Articular Chondrocytes-BAC) were collected and the plates were rinsed two times 
with sterile PBS. Adhered cells (called Bovine Articular Stem Cells-BASC) were detached from 
the plate with 0.25% trypsin/2.21 mM EDTA. BASCs were rinsed and suspended in Hoechst 
media to be analyzed for Hoechst 33342 efflux. 
 
 
5.  Isolation of bovine aggrecan monomer 
 Full thickness slices of bovine articular cartilage were excised from 18-24 month bovine 
metacarpophalangeal joints obtained from a local abattoir. The cartilage was frozen in liquid 
nitrogen, ground to a powder and extracted in a dissociative buffer consisting of 4.0 M guanidine 
HCl, 0.01 M EDTA, and 0.05 M sodium acetate (Sigma), pH 5.8 [173]. After gentle stirring at 4°C 
for 24 hours, the solution was centrifuged at 13,000 x g for 45 minutes at 4°C then passed through 
a 100 μM sieve to remove undissociated clumps. The strained solution was brought to a final 
density of 1.5 g/ml by the addition of 0.5452 g CsCl/ml. Samples were centrifuged at 100,000 x g 
for 48 h at 4°C under vacuum in a Beckman 50.2Ti rotor. Upon completion, the bottom fifth of 
each centrifuge tube was isolated, dialyzed against 0.05 M Na2SO4 for 24 hours, then water for 48 
hours, and then lyophilized [179]. The product was stored at -80°C.  
 
6.  Agarose gel electrophoresis 
Isolated bovine aggrecan monomer was dissolved in PBS and adjusted to 2 mg/ml. Samples 
were combined with 1 mg/ml pharmaceutical-grade hyaluronan (ARTZ, Seikagaku, Japan) or 
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digested with 5 Units/ml Streptomyces hyaluronidase (Sigma) for 90 minutes at 37°C. Equal 
volumes were then electrophoresed on a 1% agarose gel prepared in Tris-acetate-EDTA buffer and 
cast into 10 x 15 cm trays of a MP-1015 horizontal electrophoresis apparatus (ISI Scientific) [177, 
203]. One well was loaded with 5 μl of a 1 kb-PLUS DNA ladder (100– 12,000 bp; Thermo Fisher, 
Waltham, MA) for size reference. Electrophoresis was carried out for 30 minutes at 150V. Gels 
were fixed by incubation in 30% ethanol for 1 hour at room temperature, rinsed with water and 
then stained overnight with Stains-All. The stock Stains-All solution consisted of 0.1% Stains-All 
(ThermoFisher) dissolved in formamide. Two mls of stock Stains-All was diluted in 2 mls 
formamide, 10 mls isopropal alcohol, 200 µl 3 M Tris (Sigma), and 25.8 mls water to make the 
Stains-All working stock. Stained bands were imaged by trans-white light on the Chemi-Doc 
Imager (Bio-Rad, Hercules, CA). 
 
7.  Cell treatments 
7.1.  Adipogenic induction 
3T3-L1 cells were plated at 3 x 104 cells/cm2 in culture plates on Day -4 and incubated at 
37°C in 5% CO2 throughout adipogenesis. This concentration produced a confluent lawn of cells 
in 48 hours. Two days after reaching visual confluence in culture, 3T3-L1 cells were induced to 
undergo adipogenesis with 0.5 mM methylisobutylxanthine (Sigma), 1 uM dexamethasone 
(Sigma), and 1.7 uM insulin (Sigma) in maintenance media (MM) (Day 0; Adipo1 media). Forty-
eight hours later, medium was replaced with 1.7 uM insulin in MM (Day 2; Adipo2 media). After 
another 48 hours, medium was replaced with 0.43 uM insulin in MM (Day 4; Adipo3 media). 
Finally, after an additional 48 hrs (Day 6), the medium was switched to MM and cultures were 
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maintained in this medium until at least 10 days post induction  [204, 205]. A timeline for 3T3-L1 
adipogenesis is depicted in Figure 4. The red arrows represent media changes and when, if any, 
experimental treatments were administered.  
 
7.2.  Chondrogenic induction 
A 3T3-L1 cell suspension was made in DMEM + 10% FBS with 1% L-glutamine and 1% 
penicillin-streptomycin at a concentration of 107 cells/ml. Five spots of 10 μl were seeded onto a 
35 mm culture dish to form micromass cultures containing 105 cells each [206, 207]. Micromass 
cultures were incubated for 3 hours at 37°C in 5% CO2 to allow cells to adhere to the culture dish. 
Culture dishes containing micromass cultures were then flooded with control (DMEM + 10% FBS 
with 1% L-glutamine and 1% penicillin-streptomycin) or chondrogenic medium.  Incubation 
continued for 8 days with media changes every 2-3 days before cultures were either fixed and 
stained with alcian blue or collected for RNA isolation. 
 
The chondrogenic medium consisted of high glucose DMEM supplemented with 1% ITS 
(Sigma), 10% FBS, 1% L-glutamine, 1% penicillin-streptomycin, 25 μg/ml ascorbic acid (Sigma), 
1 mM sodium pyruvate (ThermoFisher, Waltham, MA ) and then filter sterilized before adding 
dexamethasone to 100 nM. TGF-β1 (R&D Systems, Minneapolis, MN) was added to medium to 




7.3.  4-Methylumbelleferone treatment 
A stock solution of 200 mM 4-methylumbelleferone (4-MU; Sigma) was made in 
dimethylsulfoxide-DMSO (ThermoFisher). 3T3-L1 cells that were undergoing adipogenic 
induction were treated by the addition of 200 μM 4-MU to every media change on days 0, 2, 4, 
and 6 [185], as indicated in Figure 4.  
 
7.4.  Exogenous aggrecan treatment 
Some 3T3-L1 cultures plated for a particle exclusion assay were treated with 2 mg/ml 
exogenous bovine aggrecan dissolved in DMEM + 10% FBS with 1% L-glutamine and 1% 
penicillin-streptomycin 24 hours after plating. Cultures were incubated with the aggrecan for 1 
hour at 37°C in 5% CO2. Exogenous aggrecan was also added to the RBC solution used in the 
particle exclusion assay to a concentration of 2 mg/ml.  
 
 Some 3T3-L1 cells undergoing adipogenic induction were treated with 2 mg/ml 
exogenous aggrecan dissolved in adipogenic media, Adipo1, Adipo2, Adipo3, and MM at every 
media change on days 0, 2, 4, and 6. For recovery from exogenous aggrecan treatment, Day 6 were 
adipogenically induced normally without and with 2 mg/ml exogenous aggrecan and stained with 
Oil Red O on Day 6. Samples analyzed on Day 10 include 3T3-L1 cells that were adipogenically 
induced  without or with 2 mg/ml exogenous aggrecan but also included cultures where aggrecan 
was excluded from the media change on Day 6 then stained for Oil Red O on day 10. Samples 
analyzed on Day 14 and 18 include 3T3-L1 cells that were adipogenically induced without or with 
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2 mg/ml exogenous aggrecan but also included cultures where aggrecan was excluded from the 
media change on Day 10 then stained for Oil Red O on Days 14 and 18. Oil Red O was extracted 
from samples and optical density analyzed per section 2.3.  
 
7.5.  Streptomyces hyaluronidase treatment 
Some 3T3-L1 cultures were treated with 20 Units/ml Streptomyces hyaluronidase dissolved in 
DMEM + 10% FBS with 1% L-glutamine and 1% penicillin-streptomycin for 3 hours at 37°C in 
5% CO2 before completion of particle exclusion assay or visualizing hyaluronan (section 10.2) 
[16]. 
 
7.6.  HAoligo  treatment   
HAoligos were prepared in our lab by 16 hour treatment of hyaluronan (rooster comb, Sigma 
or Life Core) with testicular hyaluronidase by Dr. Warren Knudson [211]. Twenty-four hours after 
3T3-L1 cultures were plated for a particle exclusion assay, some were treated with 200 μg/ml 
HAoligos dissolved in DMEM + 10% FBS with 1% L-glutamine and 1% penicillin-streptomycin for 
90 minutes at 37°C in 5% CO2. Additionally, after 90 minutes of incubation with HAoligos, some 
cultures were also treated with 2 mg/ml exogenous aggrecan for 1 hr at 37°C in 5% CO2 before 





7.7.  Exogenous hyaluronan treatment 
Twenty-four hours after 3T3-L1 cultures were plated for a particle exclusion assay, some 
were treated with 1 μg/ml pharmaceutical-grade ARTZ hyaluronan (Seikagaku, Japan) diluted in 
DMEM + 10% FBS with 1% L-glutamine and 1% penicillin-streptomycin 90 minutes at 37°C in 
5% CO2. Additionally, after 90 minutes of incubation with hyaluronan and rinsing twice with PBS, 
some cultures were also treated with 2 mg/ml exogenous aggrecan for 1 hr at 37°C in 5% CO2 
before completion on particle exclusion assay.   
 
8.  RNA isolation and qRT-PCR 
8.1.  RNA isolation 
3T3-L1 cells cultured for RNA isolation were washed 3 times with cold, sterile PBS then 
mixed with 400 μl or 800 μl cold TRIzol (Fisher) depending if culture was in a 12- or 6-well culture 
plate. The monolayer was mixed thoroughly with TRIzol and then the lysate was transferred to a 
1.5 ml microfuge tube and kept on ice. An equal volume of 100% ethanol was added to the lysate, 
briefly vortexed, then transferred to a quick spin column from a Direct-zolTM RNA Miniprep kit 
(Zymo Research, Irvine, CA). Samples were processed according to the manufacturer’s 
instructions. RNA concentrations were determined by absorbance at 260 and 280 nm using a 





8.2.  Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
Total RNA from 3T3-L1 cultures were converted to cDNA using the iScript cDNA 
Synthesis Kit (BioRad, Hercules, CA). Quantitative PCR was performed using the Sso-Advanced 
SYBR-Green Supermix (BioRad) and amplified on a StepOnePlus Real-Time PCR System 
(Applied Biosystems, Foster City, CA) to obtain cycle threshold (Ct) values for target levels. 
Mouse specific primer sequences are listed in Table 1. Real time efficiency (E) was calculated as 
E=10[-1/slope] [212]. The fold increase in copy numbers of mRNA was calculated as a relative ratio 




Table 1.  Primer Sequences 








































Table 1. Primer Sequences. Primers were designed using nucleotide sequences for the listed 
accession numbers with the PrimerQuest Tool by Integrated DNA Technologies (IDT). Primers 






9.  Western Blotting 
 
9.1.  Protein isolation 
3T3-L1 monolayers were rinsed twice with cold PBS before cold Cell Lysis Buffer (Cell 
Signaling) supplemented with protease and phosphatase inhibitor set 2 and set 3 (Thermo 
Scientific and Sigma, respectively) were added to wells over ice. The cells were scraped and 
transferred to a 1.5 ml microfuge tube then incubated on ice for 30 minutes. Lysates were 
centrifuged at 13,000 x g for 10 minutes at 4°C. Supernatants were transferred to clean tubes and 
stored at -80°C until they could be analyzed for protein concentration using a Bicinchoninic Acid 
(BCA) Protein Assay (Pierce, Rockford, IL).  
 
9.2.  BCA assay 
Following protein extraction from cells, aliquots of each sample were diluted 10-fold in 
lysis buffer and plated in a 96-well plate along with serial 1:10 dilutions of Bovine Serum Albumin 
(BSA) in lysis buffer for the standard curve. Two-hundred and fifty microliters of combined BCA 
protein assay reagents (Reagent A:Reagent B = 50:1) was added to each well. Plates were 
incubated for 30 minutes at 37°C before absorbance was obtained at 562 nm on a Multiskan Ascent 
plate reader (Thermo Scientific). Protein concentrations were calculated using the equation for the 




9.3.  Electrophoresis and immunoblotting 
Equal micrograms of protein lysate was mixed with 4X NuPAGE LDS Sample Buffer 
(Invitrogen) and 10X NuPAGE Reducing Agent (Invitrogen). DNase/RNase free water was added 
to each sample to level volumes. Samples were heated at 70°C for 10 minutes and then loaded into 
a 4-12% NuPAGE Bis-Tris Mini gel (Novex, Carlsbad, CA) and electrophoresed at 150 volts for 
45 minutes. Once separated, protein samples were transferred from the acrylamide gel to 
nitrocellulose membrane (Bio-Rad Laboratories, Inc.) using a Criterion blotter apparatus (Bio-Rad 
Laboratories, Inc.). The nitrocellulose membrane was then blocked in blocking buffer (5% non-fat 
dry milk in Tris buffered saline containing 0.1% Tween 20) for 1 hour at room temperature and 
rocking. Primary antibodies, either anti-C-terminal CD44 [191] or anti-GAPDH (Santa Cruz 
Biotechnology, Dallas, Texas), were diluted in blocking buffer and incubated on membranes 
overnight at 4°C with rocking. After rinsing with Tris buffered saline containing 0.1% Tween 20 
(TBST), membranes were incubated with horse-radish peroxidase (HRP)-conjugated secondary 
antibodies diluted in TBST for 1 hour at room temperature with rocking.  Donkey anti-rabbit IgG 
(Thermo Scientific) was used for anti-CD44 and donkey anti-goat IgG (Thermo Scientific) was 
used for anti-GAPDH. After secondary incubation, the membrane was rinsed and detection was 
performed using SuperSignal West Pico chemiluminescence substrate (Thermo Scientific).  The 
membrane was exposed to x-ray film and developed, then film was digitally captured using 






10.  Hyaluronan detection 
 
10.1.  Hyaluronan ELISA 
Conditioned media was collected from 3T3-L1 monolayers and centrifuged at 1,300 RPM 
for 10 minutes at 4°C to remove cellular debris. The supernatant was transferred to a new tube and 
stored at -80°C until analysis. Hyaluronan concentration was determined with the Hyaluronan 
DuoSet® with Substrate Reagent pack (R&D Systems. Minneapolis, MN) according to the 
manufacturer’s instructions. Briefly, a 96-well flat bottom, high-binding, microplate (Costar, 
Corning, NY) was coated with diluted capture reagent, sealed, and incubated overnight at 4°C. 
They next day, the wells were washed 3 times with wash buffer (0.05% Tween 20 in PBS) before 
being blocked with blocking buffer (5% Tween 20/0.05% NaN3 in PBS) for 1 hour at room 
temperature. Wells were washed 3 times in wash buffer, then standards and samples, diluted in 
reagent diluent (filtered 5% Tween 20 in PBS) if necessary, were added to wells then incubated 
for 2 hours at room temperature, sealed. Wash steps were repeated then detection reagent was 
added for 2 hours at room temperature, sealed, then washed again. The Streptavidin-HRP 
component was added to wells, the plate was sealed and incubated for 20 minutes at room 
temperature in the dark. One more series of washes was completed before the substrate solution 
was incubated in each well for 20 minutes at room temperature in the dark. Stop solution was 
added and then absorbance was read at 450 and 540 nm using a Multiskan Ascent plate reader 
(Thermo Scientific). Absorbances at 540 nm were subtracted from 450 nm readings to correct for 
optical imperfections in the plate. Standards were plotted using a best fit curve (5 or 6 order 
polynomial) and equation was used to calculate hyaluronan concentrations for samples.   
57 
 
10.2.  Visualization of hyaluronan using HABP 
3T3-L1 monolayers were plated in 4-chamber Falcon culture slides (Corning, Big Flats, NY) as 
described in section 1.3. Some cultures were treated with Streptomyces hyaluronidase as described 
in section 7.5. At time of testing, cultures were rinsed twice with PBS, then fixed with 3.7% 
paraformaldehyde for 5 minutes at 4°C. Cultures were then rinsed with 0.2 M glycine (Sigma) in 
PBS 3 times before being permeabilized with 0.5% Triton- X-100 (Sigma) for 10 minutes at room 
temperature. After rising 3 more times with 0.2 M glycine, the cultures were incubated with 4 
μg/ml biotinylated hyaluronic acid binding protein-HABP (Calbiochem, EMD MilliPore, 
Billerica, MA) diluted in 1% BSA/PBS overnight at 4°C. The next day, cultures were carefully 
rinsed and incubated in Alexa-Fluor-488 conjugated with Streptavidin (green fluorescence; 
Jackson ImmunoResearch Labs, West Cove, PA) diluted in 1% BSA/PBS for 1 hour at room 
temperature. Cultures were rinsed, chambers removed, and cover slips mounted with DAPI 
containing mounting media, FluoroGel II (Electron Microscopy Services, Hatfield, PA). 












Figure 4. Timeline for adipogenesis of 3T3-L1 cells. Cells plated on day -4, were maintained in 
DMEM+10% FBS (MM) until induction, at Day 0. Two days after reaching confluency (Day 0), 
cells were induced with 1uM Dex, 0.5 mM MIX, and 1.7 uM insulin in MM (Adipo1). On Day 2, 
cells were treated with MM+1.7 uM insulin (Adipo2). On Day 4, cells were treated with MM+0.43 
uM insulin (Adipo3). On Day 6, media was changed back to MM for the remainder of culture. 
3T3-L1 cells exhibit mesenchymal morphology at time of plating of 104 cells per cm2 on Day -4. 
If any additional experimental treatments were administered, they were done so at each medium 





CHAPTER 3: RESULTS 
 
1. Detection of a side population of progenitor cells 
1.1 Flow cytometry 
Identification and isolation of side populations using flow cytometry to detect Hoechst 33342 
dye efflux has been reported in many tissues such as muscle, liver, lung, skin, bone marrow, and 
cartilage [26, 215-219]. This method has also been used to detect a side population of progenitor 
cells within the widely used breast cancer cell line, MCF-7 [220]. We used the same MCF-7 cell 
line as a positive control to determine the conditions needed to detect a side population using flow 
cytometry. After staining MCF-7 cells with Hoechst 33342 and propidium iodide (PI) in the 
presence or absence of verapamil, the cells were analyzed with fluorescent microscopy. Verapamil, 
a calcium channel blocker traditionally administered to patients with cardiovascular issues such as 
coronary artery disease, arrhythmias, and hypertension [221], is also a P-glycoprotein inhibitor 
that  blocks cells’ ability to efflux Hoechst 33342 through action of the multi-drug resistance 
protein [222]. This serves as a control to ensure location of the side population is accurately 
determined. Even though verapamil treatment does have a slight negative effect on MCF-7 cell 
viability, which is shown by the increase in side scatter in Figure 5B and PI fluorescence in Figure 
5D compared to untreated cells (Figure 1A and C) , viable, single cells were able to be gaited for 
Hoechst 33342 fluorescent analysis. Our method determined that 0.36% of MCF-7 cells consisted 
of the side population able to efflux Hoechst 33342 (control –verapamil treated) and this efflux 





This method was then used with primary cells isolated from bovine articular cartilage; a side 
population of 0.04, 0.18, and 0.24% in 3 separate experiments was found (Figure 6, A, C, & E). 
No side population was detected when cells were treated with verapamil (Figure 6, B, D, & F). 
With such a low number of cells comprising the progenitor side population, it was unlikely that 
differentiation experiments could be completed without population expansion. Expanding the cells 
was undesirable because bovine articular chondrocytes have been shown to dedifferentiate in 
culture with just a few passages [223]. This would make it difficult to determine if the cells that 
had been isolated were truly progenitor cells or simply dedifferentiated chondrocytes.  
 
A previous study reported a higher number of progenitor cells in the more superficial articular 
cartilage zones when compared to deeper zones [28]. In an attempt to increase the percentage of 
the progenitor side population detected, cells were isolated from the superficial vs middle/deep 
layers of bovine articular cartilage (Figure 7A) and analyzed for Hoechst 33342 fluorescence 
separately. Isolated cells were stained with Hoechst 33342 and propidium iodide (PI) in the 
presence or absence of verapamil. The superficial layer of cartilage did have 3 times the percentage 
of progenitor side population detected at 0.06% (Figure 7B) compared to 0.02% for the 
middle/deep cartilage layer (Figure 7D). The verapamil treated cells had no detectable side 
population regardless of from where the cells were isolated (Figure 7C & E).  
 
1.2 Adhesion to fibronectin to enrich progenitor cells 
An alternative approach to enrich the progenitor side population, rather than clonal expansion, 
would be to select for the desired cell type. Identifying and isolating a progenitor side population 
62 
 
by differential adhesion to fibronectin was first achieved in epidermal cells [202]. This differential 
adhesion assay was later adopted in order to identify and isolate a progenitor sub-population from 
human articular cartilage [201]. We employed this method to enrich a progenitor side population 
from bovine articular cartilage. Petri dishes were coated with fibronectin and allowed to dry. Cells 
isolated from bovine articular cartilage were incubated on the fibronectin, unattached cells were 
rinsed away. The attached cells were termed Bovine Articular Stem Cells (BASC) while the cells 
that rinsed off were termed Bovine Articular Chondrocytes (BAC). At first, fibronectin was seeded 
onto the petri dishes in spots to ensure that the cells weren’t just adhering to the dish non-
discriminately. Figure 8A shows that cells adhered to the fibronectin spot and not to the uncoated 
dish. Based on previous reports, most of the cells that adhered to the fibronectin would constitute 
the progenitor side population (BASC) and would therefore be able to efflux Hoechst 33342 dye. 
Figure 8B shows that isn’t the case. Regardless of whether the cells had 5 or 20 minutes exposure 
to Hoechst 33342 at 37 or 4°C, there was no obvious difference between BASC and BAC in 
Hoechst 33342 staining observed by fluorescent microscopy. However, a side population of acute 
myeloid leukemia cells was identified using this method [200]. In order to determine if any 
Hoechst 33342 efflux could be visualized via fluorescent microscopy, three cell lines that have 
shown differentiation capabilities were utilized. Both 3T3-L1 and C3H10T1/2 cells are 
mesenchymal in origin and MG-63 cells were derived from an osteosarcoma [71, 193, 224]. Figure 
9 shows these three cells lines 1 and 3 hours after rinsing from Hoechst 33342 stain. At 3 hours, 
the cells attached and displayed their fibroblastic morphology. The 3T3-L1 cells had the most cells 
with little to no Hoechst 33342 staining, suggesting they might have the highest number of 
MDR/ABC transporters. 
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2. 3T3-L1 chondrogenic potential 
3T3-L1 cells were derived from the NIH-3T3 mesenchymal fibroblastic cell line isolated 
from a mouse embryo because of their efficient adipogenic differentiation but they are usually 
referred to as “uni-potent” towards adipocytes [225]. We demonstrated that the 3T3-L1 cell line 
effluxes Hoechst 33342 more efficiently than the mesenchymal, multipotent progenitor cell line, 
C3H10T1/2 (Figure 9).   Goodell et al. (1997) suggested that the degree of efflux activity seemed 
to correlate with the maturation state of cells, such that cells exhibiting the highest efflux activity 
are the most primitive or least restricted in terms of differentiation potential [226].  We wanted to 
test the multipotency of 3T3-L1 cells by testing their chondrogenic potential. Even though the 
parent NIH-3T3 cell line has been shown to undergo chondrogenesis, with low frequency, no work 
has been completed determining if the daughter 3T3-L1 cells are chondrogenic [227]. Micromass 
cultures and acidic alcian blue stain have been used successfully to study chondrogenesis since the 
mid-late 1970’s [206]. In this study, 3T3-L1 cells displayed strong alcian blue staining after 11 
days in micromass culture treated with chondrogenic medium (Figure 10A). The alcian blue stain 
was extracted with 4 M guanidine HCl and analyzed for absorbance which showed a statistically 
significant increase in the amount of alcian blue released from the treated 3T3-L1 micromass 
culture compared to the untreated control (Figure 10B). In addition, Acan mRNA expression was 
significantly increased compared to a non-treated micromass culture and 3T3-L1 cells in 
monolayer (Figure 10C). However, there was a significant reduction in Vcan and Has2 mRNA 
expression in the chondrogenic treated micromass cultures compared to the untreated micromasses 
or the monolayer cultures (Figure 10D & E). Even though Acan expression increased by over 10-
fold in chondrogenic micromass cultures, Vcan was still more abundant as demonstrated by the 
lower ΔCT values in Figure 10F.    
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3. Characterization of 3T3-L1 mesenchymal pericellular matrix 
During mesodermal chondrogenic differentiation for limb bud development, dynamic 
changes to the pericellular matrix take place [153]. The pericellular matrix surrounding cells is 
resistant to staining techniques and is difficult to visualize. Over the past years, many labs have 
employed a particle exclusion assay to successfully visualize the pericellular matrix [153]. This 
method is based on small inert particles (fixed red blood cells) allowed to fall down around the 
cell and matrix leaving a halo or ‘coat’. This coat is the pericellular matrix. First, we looked at the 
pericellular matrix of mesenchymal 3T3-L1 cells. The undifferentiated cells have a very 
characteristic mesenchymal morphology (Figure 11A). The particle exclusion assay reveals these 
cells to have a well-defined pericellular coat surrounding each cell (Figure 11B). After 1 hour 
treatment with exogenous aggrecan, the pericellular matrix appeared to swell and the visible coat 
became much larger (Figure 11C). When 3T3-L1 mesenchymal cells were exposed to 
Streptomyces hyaluronidase or HAoligos, the pericellular matrix was nearly completely removed 
leaving the cells barely visible under the red blood cells (Figure 11D &E). The results from 
hyaluronidase treatment indicated that the pericellular matrix is dependent on hyaluronan while 
results from HAoligos treatment suggest that the hyaluronan needs to be of high molecular weight 
to maintain the pericellular matrix. Additionally, displacement of pericellular coats by HAoligos also 
indicated that the pericellular matrix is receptor–anchored and not covalently bound. However, if 
exogenous aggrecan were added to cells that have been pre-treated with HAoligos, the pericellular 
matrix recovered and was not only visible, but of similar size to that of the untreated control (Figure 
12C), suggesting mesenchymal 3T3-L1 cells can maintain a coat with newly synthesized 




4. 3T3-L1 adipogenesis 
4.1 Induction timeline and morphological changes 
If maintained in culture medium with serum, 3T3-L1 cells will undergo adipogenesis in 2-
4 weeks [228]. However, with adipogenic inducers, that timeline for adipogenesis is shortened to 
7-10 days [229]. The general timeline used for the adipogenesis protocol is depicted in Figure 13A. 
The first day the cells were introduced to adipogenic inducers is termed Day 0. Four days before 
induction (Day -4), the cells were plated at a density of 104 cells per cm2 on a culture dish in 
DMEM + 10% FBS-called Maintenance Media (MM). At this density, the cells became confluent 
in 2 days and entered a contact inhibitory phase. Two days post-confluency, Day 0, the cells were 
induced with the adipogenic medium Adipo 1 (1 µM Dexamethasone, 0.5 mM 
methylisobutylxanthine, and 1.7 µM insulin in MM). On Day 2, cells were treated with the full 
insulin dose in a medium called Adipo 2 (1.7 µM insulin in MM). On Day 4, cells were treated 
with a fourth of the original insulin dose with Adipo 3 (0.43 µM insulin in MM). Finally, on Day 
6, the media was changed back to MM for the remainder of culture. If any experimental treatments 
were administered, they were done so at each medium change indicated by the red arrows above 
the timeline- on days 0, 2, 4, and 6 ( Figure 4 in Methods). As 3T3-L1 cells undergo adipogenesis, 
drastic morphological changes were easily visible by phase contrast imaging.  3T3-L1 cells 
exhibited mesenchymal/fibroblastic morphology at time of plating (Figure 13B). By two days post-
confluence, Day 0-the time of induction, the cells began to look a little less mesenchymal and 
started to round up like cobblestones (Figure 13C).  By Day 4, four days post adipogenic induction, 
cells had more of a polygonal/cobblestone appearance and even a few cells were starting to contain 
visible lipid droplets (Figure 13D). Ten days post induction, the majority of cells were round and 
contained many lipid droplets made visible by staining with Oil Red O (Figure 13E).  
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3T3-L1 cells were used to confirm Hoechst 33342 efflux (Figure 9). 3T3-L1 cells were 
also planned to be an adipogenic control cell line to compare with the side population cells isolated 
from bovine articular cartilage. Therefore to serve as an adipogenic control, it was necessary to 
determine first if the differentiation assay could be scaled down to use a tenth of the cells usually 
required. This was a pre-requisite because of low cell numbers detected in the side population 
described in section 1.1. Figure 14 shows results from completing an adipogenic assay in a 48 and 
96-well culture plate. 3T3-L1 cells adhered well and completed adipogenic differentiation in 48-
well plates. While the 3T3-L1 monolayer was prone to detachment in the 96-well plate, there were 
enough cells still adhered to determine that 3T3-L1 cells can undergo adipogenesis on as little as 
a 0.32 cm2 surface with an initial plating of 9,600 cells.  
 
4.2.      Markers for adipogenesis 
 One of the most commonly used markers for adipogenesis is positive Oil Red O staining. 
Oil Red O stains lipid droplets bright red and makes them easily visible by light microscopy.  
Mesenchymal 3T3-L1 cells had negligible Oil Red O staining (Figure 15A). After 3T3-L1 cells 
completed adipogenesis, the cells were round and contained many large lipid droplets that were 
highly stained (Figure 15B). Two other markers used for adipogenesis are the expression of fatty-
acid binding protein-4 (Fabp4) and peroxisome-proliferator-activated receptor gamma (Pparγ) 
[230]. Messenger RNA for both these genes had similar expression patterns during adipogenesis 
but fold change was much greater for Fabp4. Expression from Day 0 to Day 2 remained constant 
but increased on Day 4. There was a 2-fold increase in Pparγ but nearly a 100-fold increase for 
Fabp4 compared to Day 2 (Figure 15C & D). By Day 6, Pparγ increased another 3-fold and Fabp4 
increased another 50-fold compared to Day 4. Finally, on Day 10, expression of both makers 
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decreased. Pparγ showed about a 2-fold decrease while Fabp4 showed approximately a 75-fold 
decrease when compared to Day 6.   
 
4.3.      Hyaluronan release and production 
 There are several media changes during 3T3-L1 adipogenic induction and it was observed 
that the medium became noticeably viscous around Day 4 or 6 when aspirating the medium with 
a Pasteur pipette connected to a vacuum. Long strings of medium were formed between the culture 
dish and the pipette tip (Figure 16A).  If the change in viscosity had been the focus of this study, 
we could have quantified it with a viscometer (discussed more in Section 9). To determine if the 
increase in viscosity was due to an increase of hyaluronan, an ELISA was used to measure the 
hyaluronan concentration in the media collected prior to each media change (Figure 16B). The 
hyaluronan released into the media between days -4 and 0 (listed as Day 0) was the same 
concentration as the hyaluronan released between days 0 and 2 (listed as Day 2), both at around 2 
µg/ml. There was a significant increase in hyaluronan detected in the medium that was released 
between days 2 and 4 (listed as Day 4) and again between days 4 and 6 (listed as Day 6), 5.8 and 
7.8 µg/ml, respectively. Between days 6 and 10, hyaluronan detected in the medium had 
significantly decreased to 6.2 µg/ml. It is important to note that this last data point (listed as Day 
10) was for 4 days of conditioning whereas the previous data points were for 2 days (except on 
day 0, which also had 4 days of conditioning). In order to determine that the ELISA used was 
specifically detecting hyaluronan, the Day 10 sample was treated with Streptomyces hyaluronidase 
because it specifically digests hyaluronan and not other glycosaminoglycans [231]. After analysis 
the digested sample produced a reading of 0.002 ng/ml, indicating that this ELISA was appropriate 
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for detecting and measuring hyaluronan in this conditioned medium and the results were not 
altered due to interfering components.  
 
 Three hyaluronan synthases have been identified in mammals, HAS1, HAS2, and HAS3 
[232]. Total RNA was isolated and RT-PCR performed to determine which synthase was the major 
contributor to the hyaluronan detected in the conditioned media. On all days tested, -4, 0 and 10, 
Has2 was found to have the highest level of mRNA expression as shown by the lowest ΔCT value 
when compared to Has1 and Has3 in Figure 16C.  The ΔCT value was obtained by subtracting the 
Has CT (cycle threshold) value by the Gapdh CT value. This corrects for differences in sample 
metabolism. Day 0 saw the highest Has2 and Has3 expression while Days -4, and 10 were lower. 
Has1 was only detected on Day -4 and was not detected (ND) on Day 0 or Day 10.    
 
 RT-PCR was also used to determine changes in Has2 and Has3 gene expression throughout 
adipogenesis (Figure 17). Both genes followed very similar expression patterns where expression 
initially decreased, then increased, then decreased again. There was a significant decrease in gene 
expression for both on Day 2 when compared to Day 0, and then both significantly increased on 
Day 4. Another decrease was observed for Day 6 and then again for Day 10. Expression levels for 






4.4.       Pericellular matrix of 3T3-L1 adipocytes 
 Western immunoblotting was used to determine changes in CD44 protein expression in 
3T3-L1 cells on Days 0, 2, 4, 6, and 10 during adipogenesis (Figure 18A). Abundant CD44 protein 
was detected in cells that had not been treated with adipogenic inducers (Day 0) and two days post 
adipogenic induction (Day 2). There was a distinct reduction in CD44 protein detected on Day 4 
and lower still on Day 6. By ten days post adipogenic detection (Day 10), CD44 was barely 
detected as faint band. GAPDH protein expression remained unchanged throughout adipogenesis.  
  
RT-PCR was used to determine changes in mRNA expression of Cd44 and Vcan genes, 
which are relevant to pericellular matrix production during adipogenesis of 3T3-L1 cells. 
Expression of Cd44 mRNA showed an initial decrease in expression and then stayed essentially 
constant at more than 50% decrease through Day 10 (Figure 18B). However, Vcan expression 
increased slightly on Day 2 compared to Day 0 and then decreased significantly by Day 4. Vcan 
expression decreased a little more each day until it was about 90% lower than it started on Day 0 
(Figure 18C). While there was an immediate reduction in Cd44 message detected by RT-PCR two 
days after adipogenic induction, CD44 protein was present and detectable with immunoblotting 
until six days post adipogenic induction but was nearly undetectable after 10 days (Figure 18A).  
 
 Shown in Figure 11B, mesenchymal 3T3-L1 cells that had never been exposed to 
adipogenic inducers had a very prominent pericellular matrix. Even 3T3-L1 cells that had been 
exposed to adipogenic factors but retained their mesenchymal morphology had clearly visible 
coats (bottom micrographs in Figure 19A). However, once the 3T3-L1 cells differentiated into 
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adipocytes, this pericellular coat was lost (Figure 19A). Adipocytes appeared completely unable 
to form and retain a pericellular matrix. The 3T3-L1 adipocytes remained coatless even after the 
addition of exogenous aggrecan (Figure 19B), hyaluronan (Figure 19C), and the combination of 
exogenous aggrecan and hyaluronan (Figure 19D). It is important to note that the hyaluronan was 
incubated with the cells for 1 hour prior to the addition of aggrecan. This allowed time for 
exogenous hyaluronan to bind its receptor, CD44, before being decorated with the exogenous 
aggrecan. However, recall CD44 protein and mRNA expression decreased significantly during 
adipogenesis (Figure 18A and B). Only cells with mesenchymal morphology exhibited coats under 
these conditions.   
 
4.5.       Summary 
In summary, a majority of 3T3-L1 cells successfully differentiated into adipocytes after 
adipogenic induction. This was demonstrated by intense Oil Red O staining of formed lipid 
droplets 10 days post induction and significant increases in Fabp4 and Pparγ gene expression. 
Hyaluronan concentration significantly increased in culture medium during adipogenesis but 
expression of hyaluronan synthases, Has2 and Has3, did not show a significant increase in 
expression. Expression of pericellular matrix components, Cd44 and Vcan, both decreased during 
adipogenesis and adipocytes were unable to form or maintain a detectable pericellular coat. 
 
5. Effects of 4-MU on 3T3-L1 adipogenesis 
Our previous results showed that a large amount of hyaluronan was released from 3T3-L1 
cells during adipogenesis. We wanted to determine the effects of inhibiting hyaluronan synthesis 
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on the ability of 3T3-L1 cells to adipogenically differentiate. 4-methylumbelleferone (4-MU) is a 
coumarin derivative that inhibits cellular production of hyaluronan by reducing UDP-GlcUA 
available inside the cell, which is a required precursor for hyaluronan synthesis [233-235].  4-MU 
was added to the culture medium every time the medium was changed according to the timeline 
in Figure 13A.  
 
5.1 Markers of adipocyte differentiation 
4-MU significantly reduced the ability of 3T3-L1 cells to undergo adipogenesis. Figure 
20A shows strong Oil Red O staining for the control sample and no visible staining for the 4-MU 
treated cultures. A higher magnification view of the two culture conditions in Figure 20B revealed 
that almost all cells in the control sample had large lipid droplets stained with Oil Red O. However, 
even though the 4-MU treated culture showed a confluent lawn of cells, only one cell had visible 
Oil Red O staining. When the Oil Red O stain was extracted from both samples and quantified, 
the absorbance readings showed that 4-MU treatment significantly reduced the amount Oil Red O 
stain retained by the cells (Figure 20C).  
 
Phase contrast microscopy did not reveal any visible differences in morphology of the 
monolayers between control and 4-MU treated 3T3-L1 cultures for Day 2. A few round cells with 
lipid droplets were visible for the first time starting on Day 4 in the control cultures while 4-MU 
treated cells did not have visible lipid droplets until Day 6, but even then, the lipid droplets 
appeared smaller and fewer in number. On Day 10, the control cultures were largely composed of 
round adipocytes with many lipid droplets while the 4-MU treated cultures contained only a few 
adipocytes (Figure 21). Cells were counted from several micrographs (Table 2) and the 
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percentages of cells with mesenchymal or adipocyte morphology were graphed (Figure 22). After 
4 days adipogenic induction, 2% of the entire control sample population had already accumulated 
lipid droplets while a scant few were counted for the 4-MU treated sample, 0.3%. Two days later, 
50% of the entire control cell population had formed visible lipid droplets while the 4-MU treated 
sample contained 5%. By day 10, 80% of the total control cell population had visible lipid droplets 
while the 4-MU treated sample contained only 4%.   
 
  RT-PCR was used to determine gene expression of the adipogenic markers Fabp4 and 
Pparγ.  At all days tested, 2, 4, 6, and 10, Fabp4 mRNA expression was significantly decreased in 
4-MU cultures compared to controls (Figure 23A). The highest expression of Fabp4 for the 4-MU 
treated group was a 30-fold increase observed on Day 6, when compared to Day 0. This was still 
significantly lower than the expression in the control cultures, which had an average of almost a 
90-fold increase compared to Day 0.  Pparγ expression was significantly decreased by 4-MU 
treatment on Days 2, 6, and 10 when compared to the untreated control cultures (Figure 23B). All 
4-MU treated cultures had an average Pparγ expression below that of the Day 0 sample. The 
highest expression of Pparγ in control cultures was on Day 6 with an average of a 4-fold increase 
when compared to Day 0.  
 
5.2 Hyaluronan release and production 
An ELISA was used to determine if 4-MU treatment affected the amount of hyaluronan 
detected in conditioned media during 3T3-L1 adipogenesis. At each media change, the conditioned 
medium was collected, centrifuged to remove suspended cells, and then equal volumes were 
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analyzed via a commercially available hyaluronan ELISA. 3T3-L1 cells that were treated with 4-
MU during adipogenesis had significantly reduced amounts of hyaluronan detected in the 
conditioned media for all days tested (Figure 24). The highest amount of hyaluronan quantified 
for the untreated control samples was 7.6 µg/ml on Day 6, while the highest amount detected for 
the 4-MU treated samples was less than half that at 2.3 µg/ml on Day 4.     
 
RT-PCR was used to determine if the decrease in detected hyaluronan concentration in the 
culture medium for 4-MU treated 3T3-L1 cells was due to a change in hyaluronan synthase 
expression. While there was an initial decrease in Has2 expression compared to the untreated 
control on Day 2, Has2 expression was significantly increased in 4-MU treated samples compared 
to untreated for the rest of adipogenesis determined on Day 4, Day 6, and Day 10 (Figure 25A). 
However, all Has2 expression levels for both control and 4-MU treated cultures were still less than 
what was detected on Day 0. Has3 had very similar expression patterns except all 4-MU treated 
cultures had increased expression when compared to untreated control cultures on Days 2, 4, 6, 
and 10 (Figure 25B). Also, all Has3 expression levels in all cultures were less than that seen on 
Day 0.      
 
5.3.       Pericellular matrix 
A particle exclusion assay was used in order to determine if 4-MU treatment affects the 
ability of 3T3-L1 cells to form or maintain a pericellular matrix. Six or 10 days after adipogenic 
induction, with or without 4-MU treatment, 3T3-L1 cells were transferred to a new culture well 
and allowed to adhere overnight before undergoing a particle exclusion assay. Regardless of day 
tested, 3T3-L1 cells that had undergone adipogenic differentiation did not have a detectable 
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pericellular matrix while cells that remained mesenchymal had a clearly visible pericellular coat 
(Figure 26A & B). It should be noted that because so few 3T3-L1 cells undergo adipogenesis in 
the presence of 4-MU, no adipocytes were able to be tested with the particle exclusion assay. 
However, the mesenchymal cells that remained had visible coats at both 6 and 10 days (Figure 
26C & D).  
 
RT-PCR was used to determine changes in mRNA expression of pericellular matrix 
components, Cd44 and Vcan. While Cd44 expression was similar regardless of exposure to 4-MU 
on Day 2, for the remainder of the adipogenesis protocol, Cd44 expression was significantly higher 
in 4-MU treated samples when compared to untreated control (Figure 27A). However, all Cd44 
expression levels were more than 50% lower than those seen on Day 0. Very similar expression 
patterns for Vcan were observed (Figure 27B). Expression levels for Day 2 were similar regardless 
of 4-MU exposure while for the remaining days analyzed, 4-MU treated samples had a 
significantly increased Vcan expression. Expression levels for Day 2 were similar to the level 
obtained for Day 0, regardless of exposure to 4-MU. All Vcan expression levels were lower than 
those observed on Day 0 for the remainder of adipogenesis.  
 
5.4.       Summary 
Treatment with 4-MU decreased the ability of 3T3-L1 cells to undergo adipogenesis. This 
was demonstrated by an observed reduction in the number of cells containing lipid droplets in 
addition to significant decreases in adipogenic markers, Oil Red O stain and Fabp4 and Pparγ 
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mRNA expression. Hyaluronan concentration was significantly decreased in the culture medium 
but hyaluronan synthases, Has2 and Has3, were significantly increased in 4-MU treated cultures. 
4-MU treatment did not affect the ability of mesenchymal 3T3-L1 cells to form a pericellular coat 
and adipocytes were still not able to synthesize a coat. Expression of pericellular related genes, 
Cd44 and Vcan were upregulated in 4-MU treated cultures compared to the untreated control.       
 
6. Isolation of proteoglycan from bovine articular cartilage 
Aggrecan monomer is not always commercially available and even when it is, the product 
is of unknown purity and integrity. Our lab has found isolating aggrecan from bovine articular 
cartilage with a dissociative CsCl density gradient through ultra-centrifugation to be the most 
efficient at producing a consistent, quality product [177, 179]. This aggrecan isolation procedure 
is outlined in Figure 28A.  Full thickness cartilage slices were harvested from the 
metacarpophalangeal joint of 18-24 month old steers and then flash frozen in liquid nitrogen before 
being pulverized into a powder. After extracting the cartilage components in 4 M guanidine HCl, 
the extract was centrifuged in a CsCl gradient at high speed to yield the D1 (bottom) fraction 
containing the desired proteoglycan monomer. This fraction was dialyzed to dilute the CsCl and 
any remaining guanidine. After lyophilization, the aggrecan preparation was tested for purity and 
quality by electrophoresis on a 1% agarose gel. Lanes 1-4 of Figure 28B demonstrated purity of 
the isolated aggrecan. Solubilized aggrecan is shown in lane 3, while a sample pre-treated with 
Streptomyces hyaluronidase is seen in lane 4. If the aggrecan product were contaminated with the 
hyaluronan of the neighboring fraction, the band in lane 4 would have shifted. Lane 2 contains 
commercial hyaluronan while lane 1 shows this hyaluronan treated with the same Streptomyces 
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hyaluronidase to ensure the enzyme and conditions were correct for digestion. Lanes 5-7 
demonstrated the quality of the isolated aggrecan. Lane 5 contains the aggrecan monomer, 
commercial hyaluronan in lane 6, and aggrecan + hyaluronan in lane 7. When aggrecan and 
hyaluronan are combined, very large aggregates are produced that are not well resolved by 
electrophoresis. This proteoglycan aggregate is seen in the loading well of lane 7 indicating that 
the purified aggrecan retained the ability to bind hyaluronan. The isolated aggrecan was added to 
rat chondrosarcoma (RCS) cells to ensure it could bind endogenous, cellular hyaluronan and did 
not still contain any leftover deleterious agents. RCS cells were plated at subconfluent density and 
cultured for 48 hours. Using the particle exclusion assay, small pericellular matrices were observed 
surrounding the RCS cells (Figure 28C). However, following addition 2mg/ml of the isolated 
aggrecan to these RCS cultures for one hour, the sizes of the pericellular matrices were noticeably 
larger (Figure 28D). This demonstrated that the isolated aggrecan is capable of forming aggregates 
with endogenous hyaluronan. 
 
 
7. Effects of exogenous aggrecan on 3T3-L1 adipogenesis 
7.1.      Markers of adipocyte differentiation 
The addition of exogenous aggrecan significantly reduced the ability of 3T3-L1 cells to 
undergo adipogenesis. Figure 29A shows strong Oil Red O staining for the control cultures and 
much lighter staining for the aggrecan treated cultures. A higher magnification view of the two 
cultures in Figure 29B revealed that almost all cells in the control cultures had large lipid droplets 
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stained with Oil Red O. However, even though the aggrecan treated cultures appeared as a 
confluent lawn of cells, only a few cells had visible Oil Red O staining. When the Oil Red O stain 
was extracted from both samples and quantified, the absorbance readings showed that aggrecan 
addition during adipogenesis significantly reduced the amount of Oil Red O retained by the cells 
on Day 10 (Figure 29C).  
 
Phase contrast microscopy did not reveal any visible differences in monolayers between 
control and aggrecan treated 3T3-L1 cultures for Day 2. A few round cells with lipid droplets were 
visible for the first time starting on Day 4 in the control cultures while aggrecan treated cultures 
did not contain cells with visible lipid droplets until Day 6. On Day 10, the control cultures were 
largely composed of round adipocytes with many lipid droplets while the aggrecan treated cultures 
had few visible adipocytes (Figure 30).   
 
RT-PCR was used to determine gene expression of the adipogenic markers Fabp4 and 
Pparγ.  There were no significant differences in Fabp4 expression observed between aggrecan 
treated and untreated control cultures for Days 2 and 10, however, Fabp4 mRNA expression was 
significantly decreased in aggrecan treated samples on Days 4 and 6 compared to controls (Figure 
31A). There was less than a 10-fold increase in Fabp4 expression for both treated and untreated 
3T3-L1 samples on Day 2. In Day 4 cultures, there was an ~150-fold increase in Fabp4 expression 
in the controls while only a ~25-fold increase after aggrecan treatment when compared to Day 0. 
Although Fabp4 expression for the aggrecan treated cultures was still ~25-fold increase on Day 6, 
expression for the controls climbed to a ~170-fold increase. Day 10 saw the largest increase in 
Fabp4 expression for the aggrecan treated cultures at ~125-fold increase, but this was not 
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significantly different than the ~115-fold increase seen for the untreated control. Pparγ expression 
followed a very similar pattern to that of Fabp4. There were no significant differences in Pparγ 
expression observed between aggrecan treated and untreated control cultures for Days 2 and 10, 
however, Pparγ mRNA expression was significantly decreased in aggrecan treated cultures on 
Days 4 and 6 compared to control cultures (Figure 31B). There was less than a ~3-fold increase in 
Pparγ expression for both treated and untreated 3T3-L1 cultures on Day 2. Day 4 saw a little over 
a ~20-fold increase in expression for the control culture while the aggrecan treated culture was 
only a ~7-fold increase when compared to those from Day 0. While Pparγ expression for the 
aggrecan treated cultures dipped to a ~4-fold increase on Day 6, expression for the control 
remained significantly higher at a ~16-fold increase. Day 10 saw the largest increase in Pparγ 
expression for the aggrecan treated culture at a ~14-fold increase, but this was not significantly 
different than ~10-fold increase seen for the untreated 3T3-L1 culture.  
 
7.2.      Pericellular matrix 
RT-PCR was used to determine changes in mRNA expression of pericellular matrix 
components, Has2, Has3, Vcan, and Cd44. The only day Has2 expression was lower in the 
aggrecan treated cultures than the untreated controls was on Day 2 (Figure 32A). For the remaining 
days tested, 4, 6, and 10, Has2 expression in the aggrecan treated cultures was significantly higher 
than the untreated controls. While Has2 expression levels in the untreated controls never rose 
above those observed on Day 0, which was set equal to 1.0, Has2 expression on Days 4, 6, and 10 
ranged between 1.4 and 2-fold higher for the aggrecan treated cultures. Expression patterns for 
Has3 were similar to those of Has2. The only day Has3 expression was lower in aggrecan treated 
cultures than the untreated controls as on Day 2 (Figure 32B). For the remaining days tested, 4, 6, 
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and 10, Has3 expression levels in the aggrecan treated samples were higher than the untreated 
control but only significantly higher on Day 6. While Has3 expression levels in the untreated 
controls never rose above 1.5-fold higher than observed on Day 0, the largest Has3 mRNA increase 
was for the aggrecan treated cultures on Day 6 at a 3-fold increase.  
 
There were no statistically significant differences observed in Cd44 mRNA expression 
levels between 3T3-L1 cells undergoing adipogenesis with or without exposure to exogenous 
aggrecan (Figure 33A).  Expression for Day 2 was similar to Day 0 which was set equal to 1.0.  
All remaining days tested, 4, 6, and 10 demonstrated lower levels of expression with the lowest 
observed on Day 6 at 0.75-fold less than that of Day 0. Unlike Cd44 expression, aggrecan exposure 
did have a significant impact on Vcan mRNA levels. For all days tested, Vcan expression was 
significantly higher in aggrecan treated 3T3-L1 cultures than the untreated controls for the same 
day (Figure 33B). The highest Vcan expression seen for the aggrecan treated cultures was on Day 
2, which was a 15-fold increase compared to 3-fold increase for the untreated controls over Day 
0. The highest expression for the untreated controls was observed on Day 4, a 7-fold increase, 
while the aggrecan treated 3T3-L1 sample was significantly higher at a 10-fold increase as 
compared to Day 0.  
 
 
7.3.       Partial recovery of adipogenesis 
The previous sections demonstrated that exposure to exogenous bovine aggrecan inhibited 
adipogenesis of 3T3-L1 cells. Because there were no significant differences in adipogenic markers, 
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Fabp4 and Pparγ, on Day 10, that may suggest the 3T3-L1 cells are able to overcome the inhibitory 
effects of aggrecan if allowed to differentiate a little longer without aggrecan. To determine if 
adipogenesis of 3T3-L1 cells could recover, cells were treated with exogenous aggrecan in 
induction media for 6 days or 10 days, then fresh MM was added excluding the aggrecan. Figures 
34 and 35 depict micrographs of 3T3-L1 monolayers after fixation and Oil Red O staining at 400 
and 600x final magnification, respectively. Only samples for untreated control and aggrecan 
treated are present for Day 6 because this was the first day aggrecan was excluded from the culture 
medium. The control cultures contained many more cells with visibly stained lipid droplets than 
the aggrecan treated cultures.  Day 10 shows similar results to Day 6, the control sample had many 
more stained cells than did the aggrecan treated sample. 3T3-L1 cells that were exposed to 
aggrecan until Day 6 of the adipogenesis protocol but switched to MM from Day 6 to Day 10 are 
shown under “+/- Aggrecan” for Day 10.  The absence of aggrecan for the remaining 4 days of the 
adipogenesis protocol appeared to result in a slight increase in the number of adipocytes compared 
to the cultures that contained aggrecan for the entire adipogenesis protocol (+Aggrecan). The Day 
14 and 18 images depict control 3T3-L1 cultures that completed adipogenesis untreated and were 
maintained in MM for 4 and 8 additional days, cultures that were treated with aggrecan during 
adipogenesis and with aggrecan added to the MM for 4 and 8 extra days, and 3T3-L1 cultures that 
were treated with aggrecan during adipogenesis but then not exposed to aggrecan for the 4 and 8 
extra days while in MM (+/-Aggrecan). Cultures that were treated with exogenous aggrecan for 
the entire culture period had visibly fewer stained adipocytes than did the untreated control cultures 
for both Days 14 and 18. Additionally, cultures that had aggrecan removed from culture on Day 
10 (+/-Aggrecan), appeared to have slightly more stained adipocytes than the cultures that were 
exposed with exogenous aggrecan for the entire experiment. However, the +/- Aggrecan cultures 
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had noticeably fewer adipocytes than did the untreated control cultures. Adipocytes that were 
cultured for 14 and 18 days in the control conditions appeared to have larger lipid droplets than 
the cells of all the other cultures (Figure 34). 
 
As an indirect way to quantify the amount of adipogenesis that occurred in 3T3-L1 cultures 
treated with and without exogenous aggrecan, Oil Red O stain was ethanol extracted and 
absorbance was obtained (Figure 36). 3T3-L1 cultures treated with aggrecan to Day 6 had less Oil 
Red O staining than untreated controls. This observation was made for all days tested. There was 
an increase in Oil Red O staining for both aggrecan treated and untreated cultures on Day 10 
compared to Day 6. Cultures that were treated with aggrecan for 6  or 10 days of adipogenesis and 
then not for the remainder of the experiment had a statistically significant increase in Oil Red O 
staining when compared to cultures treated with aggrecan for the entire duration of adipogenesis. 
Although this trend was observed for all days tested, the amount of staining for these cultures never 
increased to what was observed in the untreated control cultures.  
 
 
7.4.      Summary 
Treatment with exogenous bovine aggrecan decreased the ability of 3T3-L1 cells to 
undergo adipogenesis. This was demonstrated by an observed reduction in the number of cells 
containing lipid droplets in addition to significant decreases in adipogenic markers, Oil Red O 
staining and Fabp4 and Pparγ mRNA expression. Hyaluronan concentration could not be 
determined in aggrecan treated samples because of interference with hyaluronan detection. 
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However, hyaluronan synthases, Has2 and Has3, were significantly increased in aggrecan treated 
cultures. Expression of pericellular related gene, Cd44, was not significantly affected by aggrecan 
treatment but Vcan was significantly upregulated compared to the untreated control. When 
aggrecan was removed from previously treated samples, 3T3-L1 cells were able to partially 
recover their adipogenic capabilities when culture periods were extended.   
 
8. Visualization of hyaluronan internalization 
To determine if hyaluronan was internalized by the 3T3-L1 cells during adipogenic 
differentiation, the cells were fixed, permeabilized, and incubated with a commercially available 
biotinylated hyaluronan binding protein (bHABP) followed by avidin conjugated to a fluorophore 
to visualize hyaluronan (-SH). Some cells were pre-treated with Streptomyces hyaluronidase 
(+SH) to remove extracellular hyaluronan so only intracellular hyaluronan would be visible. Figure 
37 depicts fluorescent micrographs of 3T3-L1 cells during adipogenesis probed with bHABP for 
hyaluronan (green) and with DAPI for nuclear staining (blue). Mesenchymal 3T3-L1 cells (-SH) 
had intense fluorescence for hyaluronan but that was reduced for the +SH treated cells indicating 
most of the hyaluronan is located externally. Confluent 3T3-L1 cells lost intensity of external 
hyaluronan fluorescence on Day 0, but regained it by Day 2. SH treatment revealed that there is 
little internal hyaluronan until cells contained lipid droplets (from day 4 to 10) which then appeared 
to be outlined by the hyaluronan. Figure 38 contains fluorescent micrographs of 3T3-L1 cells 
treated with exogenous bovine aggrecan throughout adipogenesis. These cells were also probed 
with bHABP and DAPI and show similar results to those in Figure 37 in that 3T3-L1 cells did not 
exhibit intense internal hyaluronan fluorescence until differentiation into adipocytes.     
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9.       Limitations of study 
The low recovery of side population cells from bovine articular cartilage limited the 
proposed studies using these cells.  Nonetheless, this study achieved its aim to gain insight into 
how hyaluronan and its associated components participate in directing adipogenesis of 3T3-L1 
cells but contained some limitations worth mentioning.  First, it is important to emphasize that any 
RNA or protein samples obtained from cell cultures at different stages during adipogenesis 
contained cells at various stages of differentiation. In some experiments, such as the particle 
exclusion assay, this mixed population was beneficial because there was essentially a control 
(undifferentiated mesenchymal) population of cells in the same well as differentiating cells. 
However, RNA collected from cells during adipogenic differentiation consisted of RNA isolated 
from undifferentiated mesenchymal cells as well as fully differentiated adipocytes and the stages 
in between. From these data, it is unclear what percentage of cells had altered gene expression and 
we can only conclude that the average gene expression for the whole cell population changed. This 
resulted in increased variability from experiment to experiment and could have interfered with the 
statistical analysis. Nonetheless, statistical significance was shown for many data points and 
supports the trends of differentiation revealed in this study.  
 
The shift in focus of this study was prompted by the observation that culture medium of 
differentiating 3T3-L1 cells was more viscous than that of mesenchymal 3T3-L1 cells.  At no point 
was the actual viscosity measured and observations were simply made while aspirating the 
medium. This observation could have been easily quantified with an Ubbelohde viscometer, mass 
spectrometry, or size exclusion chromatography.  Media samples were collected and stored for all 
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time points tested so the viscosity could be analyzed for a future study that has more emphasis on 
comparing viscosity at various time points during adipogenesis.  
 
Lastly, a lot of trust was placed into ZenBio, Inc. to provide a pure culture of 3T3-L1 cells 
as we did not authenticate their identity or purity. The biggest concern for contamination lies with 
our novel finding that 3T3-L1 cells have chondrogenic potential. The 3T3-L1 cell line was derived 
from the parental NIH-3T3 cell line which is capable of undergoing chondrogenic differentiation 
[236]. Studies using chondrogenic media and micromass cultures of mesenchymal cells require a 
high cell number density for cell-cell interactions to generate aggrecan-positive cartilage nodules. 
This study used the same preparation of 3T3-L1 cells for both chondrogenic and adipogenic 
differentiation. The parental NIH-3T3 does not undergo efficient adipogenic differentiation under 
the same conditions as 3T3-L1 cells [237] and since this study observed consistently efficient 
adipogenesis with recommended 3T3-L1 adipogenesis conditions, it is unlikely there is significant, 
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Figure 5. Verification of side population detection method using flow cytometry. 
MCF-7 cells were stained with 10 μg/ml Hoechst 33342 and 2 μg/ml propidium iodide (PI) after 
treatment with (B, D, F) and without (A, C, E) 50 μM verapamil and then analyzed via flow 
cytometry to determine the presence of a side population. Cell singlets versus doublets were 
determined using FSC-A (forward scatter)/SSC-A (side scatter) analysis. Cell doublets were 
excluded and only cell singlets were gated (inside polygons) for analysis (A+B). Live versus dead 
cells were determined using PI fluorescence (FL2-H) plotted against forward scatter. Only live 
cells were gated (inside polygon) and analyzed (C+D). Single, live cells were analyzed for Hoechst 
33342 fluorescence using blue (FL4-H) and red (FL5-H) channels. Dots enclosed in polygons 
represent the side population of MCF-7 cells with the percentage of side population out of total 




            
              
















Figure 6. Detection of side population in cells isolated from bovine articular cartilage. 
Primary cells, isolated from articular cartilage of bovine metacarpophalangeal joints, were stained 
with 10 μg/ml Hoechst 33342 and 2 μg/ml propidium iodide (PI) with (B, D, F ) and without (A, 
C, E)  50 μM verapamil treatment and then analyzed via flow cytometry to detect a side population. 
Single, live cells were determined using forward vs. side scatter and PI staining and then analyzed 
for Hoechst 33342 fluorescence using blue (FL4-H) and red (FL5-H) channels. Percentage of side 










                     




File: SamanSP_10July 2015.001 Log Data Units: Linear Values
Acquisition Date: 10-Jul-15 Gate: G1
Gated Ev ents: 89779 Total Ev ents: 100000
X Parameter: FL5-H (Linear) Y Parameter: FL4-H (Linear)
Region Ev ents % Gated % Total X Mean Y Mean Y Geo Mean Px,Py
R1 89779 100.00 89.78 525.70 502.60 467.65 1, 2




File: SamanSP_10July 2015.002 Log Data Units: Linear Values
Acquisition Date: 10-Jul-15 Gate: G1
Gated Ev ents: 34227 Total Ev ents: 100000
X Parameter: FL5-H (Linear) Y Parameter: FL4-H (Linear)
Region Ev ents % Gated % Total X Mean Y Mean Y Geo Mean Px,Py
R1 34227 100.00 34.23 666.39 607.84 559.30 1, 2




File: SamanSP_10July 2015.003 Log Data Units: Linear Values
Acquisition Date: 10-Jul-15 Gate: G1
Gated Ev ents: 83200 Total Ev ents: 100000
X Parameter: FL5-H (Linear) Y Parameter: FL4-H (Linear)
Region Ev ents % Gated % Total X Mean Y Mean Y Geo Mean Px,Py
R1 83200 100.00 83.20 497.89 461.42 436.28 1, 2




File: SamanSP_10July 2015.004 Log Data Units: Linear Values
Acquisition Date: 10-Jul-15 Gate: G1
Gated Ev ents: 30102 Total Ev ents: 100000
X Parameter: FL5-H (Linear) Y Parameter: FL4-H (Linear)
Region Ev ents % Gated % Total X Mean Y Mean Y Geo Mean Px,Py
R1 30102 100.00 30.10 630.18 505.48 462.27 1, 2






























Figure 7. Detection of side population in cells isolated from superficial and middle/deep 
layers of bovine articular cartilage. Thin, superficial slices of cartilage tissue were harvested 
from the upper condyles of bovine metacarpophalangeal joints leaving both middle and deep 
cartilage layers behind. An additional layer was harvested as the middle/deep cartilage layer (A). 
Primary cells were isolated from these separate superficial and middle/deep layers and stained with 
10 μg/ml Hoechst 33342 and 2 μg/ml propidium iodide (PI) with (C & E) and without (B & D) 50 
μM Verapamil treatment and then analyzed via flow cytometry to detect a side population. Single, 
live cells were determined using forward vs. side scatter and PI staining and then analyzed for 
Hoechst 33342 fluorescence using blue (FL4-H) and red (FL5-H) channels. Percentage of side 







    

















Figure 8. Isolation of side population using fibronectin adhesion. Primary cells isolated from 
bovine articular cartilage were allowed to adhere to fibronectin spots coated onto sterile petri 
dishes for 20 minutes at 37°C then rinsed. One spot is shown in panel A (Bar = 1000 µm). Cells 
that were able to adhere to fibronectin are termed Bovine Articular Stem Cells (BASC) and 
comprise the side population. Cells that did not adhere where collected and termed Bovine 
Articular Chondrocytes (BAC). Both populations were incubated with 10 μg/ml Hoescht 33342 
for 5 or 20 minutes at 4 or 37°C, rinsed, and then microscopically observed for Hoechst 
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Figure 9. Determination of Hoechst 33342 efflux from various cell lines. 3T3-L1, C3H10T1/2, 
and MG-63 cells were incubated with 10 μm/ml Hoechst 33342 for 5 minutes at 37°C. After 
centrifugation and re-suspension, the cells were plated in culture dishes and incubated at 37°C. 
Hoechst 33342 efflux was checked by microscopic observation at 1 (top row) and 3 hours (bottom 
row). White arrows indicate representative fluorescing cells (A). Two micrographs of 1 hour 
incubation and 1 micrograph of 3 hour incubation were used to count cells for each cell type and 
summed in the chart depicted in panel B. Cells that did not efflux Hoechst 33342 are represented 
by dark blue and cells that did efflux Hoechst 33342 are represented by light blue in the bar graph 
shown in C. The percentage of cells that had not effluxed Hoechst 33342 stain (blue cells) 
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Figure 10. Chondrogenic potential of 3T3-L1 cells.  Micromass cultures of 3T3-L1 cells were 
incubated with a without a chondrogenic medium for 10 days and then stained with Alcian blue 
(A).  Alcian blue stain was extracted from micromass cultures with overnight incubation of 4 M 
gaunidine HCl and absorbance was obtained at a 592 nm wavelength (B).  Bars in B represent the 
mean + standard deviation from 3 independent experiments analyzed in duplicate. Total RNA was 
extracted from micromass cultures after 10 days incubation with (mm treated) and without (mm 
CTL) a chondrogenic medium. The relative fold change of Acan (C), Vcan (D), and Has2 (E) 
mRNA were quantified using the ΔΔCT method using a 3T3-L1 monoculture as the control (Mono 
CTL) and normalizing with Gapdh mRNA expression.  Bars in C, D, and E represent the mean + 
standard deviation from 2 independent experiments analyzed in duplicate. The relative detection 
of Acan and Vcan mRNA are represented as mean ΔCT values in panel F.  ΔCT values equal the 
gene of interest CT value – reference gene (Gapdh) CT value which compensates for differences 
in cell sample metabolisms.  Values are inversely proportional to relative amount of mRNA 







      










Figure 11. Effects of exogenous aggrecan, Streptomyces hyaluronidase and HAoligos on 
pericellular matrices of mesenchymal 3T3-L1 cells. The pericellular matrix (PCM) assembled 
by cells is composed largely of water and difficult to visualize with traditional staining methods. 
Adding small inert particles, like formalin fixed red blood cells (RBC) that settle down around the 
living cell and are excluded from its matrix creates a halo. This halo represents the PCM or ‘coat’ 
of each cell. Mesenchymal 3T3-L1 cells appear elongated in shape (A) and have easily detected 
PCMs (B) that are increased in size with the addition of exogenous aggrecan (C). These coats are 
no longer detected when 3T3-L1 cells are treated with 20 U/ml Streptomyces hyaluronidase (SH) 
(D) or 200 μg/ml HAoligos (E). Panels depict representative cells, Bars = 100 μm, original 




    







+HAoligos +HAoligos +Aggrecan 
100 
 
Figure 12. Effects of adding exogenous aggrecan after HAoligos treatment on pericellular 
matrices (PCMs) of mesenchymal 3T3-L1 cells. Control 3T3-L1 cells have detectible PCMs (A) 
that are decreased in size after treatment with 200 μg/ml HAoligos for 90 minutes (B). However, the 
PCM is recovered after treatment with 2 mg/ml exogenous aggrecan treatment for 1 hour in fresh 
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Figure 13.  Adipogenesis of 3T3-L1 cells.  As 3T3-L1 cells undergo adipogenesis, drastic 
morphological changes are easily visible by phase contrast imaging.  The timeline for the 
adipogenesis protocol is outlined in A. Cells are plated on day -4, then maintained in DMEM+10% 
FBS (MM) until induction, at Day 0. Two days after reaching confluency (Day 0), cells were 
induced with 1uM Dex, 0.5 mM MIX, and 1.7 uM insulin in MM (Adipo1). On Day 2, cells were 
treated with MM+1.7 uM insulin (Adipo2). On Day 4, cells were treated with MM+0.43 uM 
insulin (Adipo3). On Day 6, media was changed back to MM for the remainder of culture. If any 
additional experimental treatments were administered, they were done so at each medium change 
indicated by the red arrows above the timeline. 3T3-L1 cells exhibit mesenchymal morphology at 
time of plating of 104 cells per cm2 on Day -4 (B). Two days post-confluence, cells begin to have 
a cobblestone appearance (C).  Four days post adipogenic induction, lipid droplets begin to form 
(D). Ten days post induction, the majority of cells are round and contain many lipid droplets made 















Figure 14.  Miniaturization of adipogenic assay.  3T3-L1 cells were plated at 104 cells per cm2 
in 48 or 96-well culture plates and grown with (Adipogenic) and without (Control) adipogenic 
inducers. Ten days after induction, following the scheme in 9A, cell monolayers were stained with 






























































Figure 15.  Adipogenesis of 3T3-L1 cells is verified with Oil Red O stain and increases in 
Fabp4 and Pparγ mRNA expression.  The most identifying characteristic of adipocytes is the 
collection of large lipid droplets made visible with Oil Red O. Mesenchymal 3T3-L1 cells do not 
display any Oil Red O staining (A) while 3T3-L1 adipocytes have many lipid droplets made 
observable with Oil Red O stain (B). Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 
days after induction with adipogenic media. The relative fold change of Fabp4 (C) and Pparγ (D) 
mRNA was quantified using the ΔΔCT method using Day 0 as the control and normalizing with 
Gapdh mRNA expression.  Bars represent the mean + standard deviation from 7 experiments 
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Figure 16. Changes in hyaluronan production and release during 3T3-L1 adipogenesis.  
During adipogenesis of 3T3-L1 cells, conditioned medium becomes noticeably viscous by Day 6. 
This is demonstrated in panel A by the tension string created when the medium is aspirated with a 
Pasteur pipette.  Media collected from 3T3-L1 cells during adipogenesis on Days 0, 2, 4, 6 and 10 
were analyzed for hyaluronan (HA) concentration using a commercially available HA ELISA kit. 
To ensure the specificity of HA detection, the Day 10 sample was treated with 20 U/ml 
Streptomyces hyaluronidase and analyzed for HA content which is represented by the red bar. Bars 
represent the average + standard deviation (B). Total RNA was isolated from 3T3-L1 cells at time 
of plating, Day -4, the day on induction, Day 0, and 10 days after induction with adipogenic media, 
Day 10. The relative detection of Has2, Has3 and Has1 mRNA levels are represented as ΔCT 
values + standard deviation.  ΔCT values equal the gene of interest CT value – reference gene 
(Gapdh) CT value.  Values are inversely proportional to relative amount of Has (smaller numbers 
mean larger amounts of Has mRNA; C).  Values listed for Has2 and Has3 in panel C are graphed 































































Figure 17. Analysis of Has2 and Has3 expression during 3T3-L1 adipogenesis.  Total RNA 
was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after induction with adipogenic media.  The 
relative fold change of Has2 (A) and Has3 (B) mRNA was quantified using the ΔΔCT method 
using Day 0 as the control and normalizing with Gapdh mRNA expression.  Bars represent the 
mean + standard deviation from 5 experiments analyzed in duplicate.  

























































Figure 18. Analysis of Cd44 and Vcan expression during 3T3-L1 adipogenesis.  Total protein 
and RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after induction with adipogenic 
media.  Protein expression of CD44 and GAPDH (as loading control) were determined by Western 
blotting with bands present at approximately 85 kDa for CD44 and 37 kDa for GAPDH (A).  The 
relative fold change of Cd44 (B) and Vcan (C) mRNA was quantified using the ΔΔCT method 
using Day 0 as the control and normalizing with Gapdh mRNA expression.  Bars represent the 






































































Figure 19.  3T3-L1 adipocytes do not have a detectable pericellular matrix.  Ten days after 
adipogenic induction, 3T3-L1 cells were re-plated at a lower density and submitted to a particle 
exclusion assay the next day. Cells that had undergone adipogenesis, as noted by their round shape 
and presence of lipid droplets (circled in red if not stained green), did not have any visible 
pericellular matrix (PCM) while cells that remained mesenchymal had clearly visible PCMs (A). 
The addition of 2 mg/ml exogenous aggrecan for 1 hour (B), 100 µg/ml hyaluronan (C), or 
hyaluronan + aggrecan (D) had no effect on the ability of 3T3-L1 adipocytes to assemble a PCM 
but enlarged the PCM of mesenchymal 3T3-L1 cells. Four different representative images are 
shown for each treatment group. For some samples, 1 μM Calcein AM fluorescence (green) was 







































Figure 20. Effects of 4-methylumbelliferone (4-MU) treatment on lipid droplet formation in 
adipogenically induced 3T3-L1 cells. Culture dishes with 3T3-L1 cells were stained with Oil 
Red O 10 days post adipogenic induction with and without 200 uM 4-MU treatment according to 
the red arrows in 9A. Representative wells are depicted in panel A.  Representative micrographs 
of cells from culture dishes from panel A are shown in panel B. After Oil Red O stain was extracted 
from the cell monolayers with 100% ethanol, the absorbance was measured at wavelength of 492 
nm (C). Bars represent the average absorbance + standard deviation for 3 independent experiments 






      
      
      






























Figure 21. 3T3-L1 cells treated with 4-methylumbelliferone (4-MU) during adipogenesis. 
Representative phase contrast micrographs show 3T3-L1 monolayers 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without treatment of 200 μM 4-MU as shown in (Figure 
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Figure 22. Effects of 4-methylumbelliferone (4-MU) treatment on mesenchymal versus 
adipocyte 3T3-L1 cell number. Mesenchymal 3T3-L1 cells and 3T3-L1 adipocytes were counted 
from micrographs 0, 2, 4, 6, and 10 days after adipogenic induction. Mesenchymal cells are 
represented by blue portion while adipocytes are represented by red portion of each bar. The 
percentage of adipocytes of the total cells counted is shown at the top of each bar for that sample.  
 
Table 2. Number of mesenchymal versus adipocyte 3T3-L1 cells with and without 4-
methylumbelliferone (4-MU) treatment.  Mesenchymal 3T3-L1 cells and 3T3-L1 adipocytes 
were counted from micrographs 0, 2, 4, 6, and 10 days after adipogenic induction. This table shows 
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Figure 23. Effects on Fabp4 and Pparγ expression during 3T3-L1 adipogenesis with and 
without 4-MU treatment.  Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without 200 μM 4-MU as shown in Figure 4. The 
relative fold change of Fabp4 (A) and Pparγ (B) mRNA was quantified using the ΔΔCT method 
using Day 0 as the control and normalizing with Gapdh mRNA expression.  Bars represent the 
mean + standard deviation from 3 experiments analyzed in duplicate.  



























Hyaluronan in 3T3-L1 conditioned media during adipogenesis







Figure 24. Effects of 4-MU treatment on HA in 3T3-L1 conditioned media during 
adipogenesis. Media collected from 3T3-L1 cells during adipogenesis without treatment (CTL-
blue line) or with 200 μM 4-MU (4-MU-red line) on Days 0, 2, 4, 6 and 10 were analyzed for HA 
concentration using a commercially available HA ELISA kit. The maintenance medium (MM) was 
analyzed to determine if it contributed to calculated HA concentrations (represented by a green 
square at Day 0). To ensure the specificity of HA detection, the Day 10 sample was treated with 
20 U/ml S. hyaluronidase and analyzed for HA content (represented by the blue triangle at Day 
10). Points represent the average + standard deviation of 2 independent experiments run in 
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Figure 25. Effects on Has2 and Has3 expression during 3T3-L1 adipogenesis with and 
without 4-MU treatment. Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without 200 μM 4-MU as shown in Figure 4. The 
relative fold change of Has2 (A) and Has3 (B) mRNA was quantified using the ΔΔCT method 
using Day 0 as the control and normalizing with Gapdh mRNA expression.  Bars represent the 
mean + standard deviation from 3 independent experiments analyzed in duplicate.                     
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Figure 26. Effects of 4-MU treatment on 3T3-L1 pericellular matrix. 3T3-L1 cells were 
induced to undergo adipogenesis without or with the addition of 200 M 4-MU as shown in Figure 
4.  The pericellular matrix (PCM) was revealed by a particle exclusion assay. 3T3-L1 cells induced 
without 4-MU treatment are shown at Day 6 (A) and Day 10 (B) and cells induced with 4-MU 
treatment are shown also for Day (6) and Day 10 (D). Because few 3T3-L1 cells treated with 4-
MU undergo adipogenesis, no adipocytes were found in plated samples to analyze during particle 
exclusion assay. Only cells with mesenchymal morphology and a PCM were observed. Adipocytes 
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Figure 27.  Effects on Cd44 and Vcan expression during 3T3-L1 adipogenesis with and 
without 4-MU treatment. Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without 200 μM 4-MU as shown in Figure 4. The 
relative fold change of Cd44 (A) and Vcan (B) mRNA was quantified using the ΔΔCT method 
using Day 0 as the control and normalizing with Gapdh mRNA expression.  Bars represent the 
mean + standard deviation from 3 independent experiments analyzed in duplicate.                                                   






















Figure 28. Isolation of aggrecan from bovine articular cartilage. Panel A depicts a flow chart 
for aggrecan isolation from bovine articular cartilage. First, full thickness slices are removed from 
the metacarpophalangeal joint of 18-24 month old steers. The slices are flash frozen in liquid 
nitrogen and ground into a powder. 4M guanidine HCl is used to dissociate individual cartilage 
components that were then separated by density with ultracentrifugation in cesium chloride. The 
densest fraction (D1) containing the aggrecan was dialyzed to remove guanidine and cesium 
chloride before lyophilization. The product was reconstituted in water and run on a 1% agarose 
gel (lanes 3 and 5). One sample was pre-treated with Streptomyces hyaluronidase for 3 hours prior 
to loading gel (lane 4).  Another sample was combined with hyaluronan for 1 hour prior to loading 
(7). Hyaluronan alone was run on lanes 2 and 6 and was treated with Streptomyces hyaluronidase 
for one hour prior to loading on lane 1. DNA ladders are marked as L. Rat chondrosarcoma cells 
were cultured for 48 hours. One culture was pre-treated with 2 mg/ml of the isolated aggrecan for 
1 hour. The pericellular matrix of cells both untreated (C) and pre-treated (D) cultures was 




































Figure 29.  Effects of exogenous aggrecan treatment on lipid droplet formation in 
adipogenically induced 3T3-L1 cells. Culture dishes with 3T3-L1 cells were stained with Oil 
Red O 10 days post adipogenic induction with and without 2 mg/ml exogenous aggrecan added at 
the time points indicated in Figure 9A. Representative wells are depicted in panel A.  
Representative micrographs of cells from the culture dishes in panel A are shown in panel B. The 
Oil Red O stain was extracted from the cell monolayers with 100% ethanol and absorbance was 
measured at 492 nm (C). Bars represent the average absorbance + standard deviation for 3 





        
         
         































Figure 30. 3T3-L1 cells treated with exogenous aggrecan during adipogenesis. Representative 
micrographs are shown of 3T3-L1 monolayers 0, 2, 4, 6, and 10 days after induction with 
adipogenic media with and without treatment of 2 mg/ml exogenous aggrecan by phase contrast 
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Figure 31. Fabp4 and Pparγ expression during 3T3-L1 adipogenesis with and without 
addition of exogenous aggrecan. Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 
days after induction with adipogenic media with and without the addition of 2 mg/ml exogenous 
bovine aggrecan as shown in Figure 4. The relative fold change of Fabp4 (A) and Pparγ (B) mRNA 
was quantified using the ΔΔCT method using Day 0 as the control and normalizing with Gapdh 
mRNA expression.  Bars represent the mean + standard deviation from 3 and 2 independent 
experiments for Fabp4 and Pparγ, respectively, analyzed in duplicate.           
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Figure 32. Has2 and Has3 expression during 3T3-L1 adipogenesis with and without addition 
of exogenous aggrecan. Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without the addition of 2 mg/ml exogenous bovine 
aggrecan as shown in Figure 4. The relative fold change of Has2 (A) and Has3 (B) mRNA was 
quantified using the ΔΔCT method using Day 0 as the control and normalizing with Gapdh mRNA 
expression.  Bars represent the mean + standard deviation from 3 and 2 independent experiments 
for Has2 and Has3, respectively, analyzed in duplicate.   
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Figure 33. Cd44 and Vcan expression during 3T3-L1 adipogenesis with and without addition 
of exogenous aggrecan. Total RNA was isolated from 3T3-L1 cells 0, 2, 4, 6, and 10 days after 
induction with adipogenic media with and without the addition of 2 mg/ml exogenous bovine 
aggrecan as shown in Figure 4. The relative fold change of Cd44 (A) and Vcan (B) mRNA was 
quantified using the ΔΔCT method using Day 0 as the control and normalizing with Gapdh mRNA 
expression.  Bars represent the mean + standard deviation from 3 independent experiments 
analyzed in duplicate.                                    





        
             
             
             

























Figure 34. Adipogenesis of 3T3-L1 cells in the presence or absence of exogenous aggrecan 
during adipogenic induction. 3T3-L1 cells were adipogenically induced in the presence or 
absence of 2 mg/ml exogenous aggrecan and then stained with Oil Red O. Micrographs for Day 6 
depict 3T3-L1 cells that were adipogenically induced without (Control) or with (+Aggrecan) 2 
mg/ml exogenous aggrecan. Day 10 micrographs display 3T3-L1 cells that were adipogenically 
induced without (Control) or with (+Aggrecan) 2 mg/ml exogenous aggrecan but include a culture 
where the aggrecan was excluded from the media change on Day 6 (+/-Aggrecan). Micrographs 
for Day 14 and Day 18 depict 3T3-L1 cells that were adipogenically induced without (Control) or 
with (+Aggrecan) 2 mg/ml exogenous aggrecan and include a culture where aggrecan was 
excluded from the media change on Day 10 (+/-Aggrecan). Micrographs are representative of 2 






            
             
             
























Figure 35. Adipogenesis of 3T3-L1 cells in the presence or absence of exogenous aggrecan 
during adipogenic induction. 3T3-L1 cells were adipogenically induced in the presence or 
absence of 2 mg/ml exogenous aggrecan and then stained with Oil Red O. Micrographs for Day 6 
depict 3T3-L1 cells that were adipogenically induced without (Control) or with (+Aggrecan) 2 
mg/ml exogenous aggrecan. Day 10 micrographs display 3T3-L1 cells that were adipogenically 
induced without (Control) or with (+Aggrecan) 2 mg/ml exogenous aggrecan but include a culture 
where the aggrecan was excluded from the media change on Day 6 (+/-Aggrecan). Micrographs 
for Day 14 and Day 18 depict 3T3-L1 cells that were adipogenically induced without (Control) or 
with (+Aggrecan) 2 mg/ml exogenous aggrecan and include a culture where aggrecan was 
excluded from the media change on Day 10 (+/-Aggrecan). Micrographs are representative of 2 












CTL Agg CTL Agg Agg to
D6
CTL Agg Agg to
D10
CTL Agg Agg to
D10





















Figure 36. Oil Red O stain quantification of 3T3-L1 cell adipogenesis in the presence or 
absence of exogenous aggrecan. 3T3-L1 cells were adipogenically induced in the presence or 
absence of 2 mg/ml exogenous aggrecan added at time points indicated in Figure 9A. Day 6 
samples consist of 3T3-L1 cells that were adipogenically induced with (Agg) and without (CTL) 
2 mg/ml exogenous aggrecan and stained with Oil Red O on day 6. Day 10 samples are 3T3-L1 
cells that were adipogenically induced with (Agg) and without (CTL) 2 mg/ml exogenous aggrecan 
but include cultures where the aggrecan was excluded from the media change on Day 6 (Agg to 
D6) and stained for Oil Red O on day 10. Samples for Day 14 and Day 18 have 3T3-L1 cells that 
were adipogenically induced with (Agg) and without (CTL) 2 mg/ml exogenous aggrecan and 
include cultures where aggrecan was excluded from the media change on Day 10 (Agg to D10) 
and stained for Oil Red O on days 14 or 18, respectively. Oil Red O was extracted from samples 
with 100% ethanol and absorbance read at a 492 nm wavelength. Bars represent absorbance mean 
+ standard deviation of 2 independent experiments.         




               
               
                 
               
               












































               
               
               
               
               










































Figure 37. Detection of intracellular and extracellular hyaluronan (HA) associated with 3T3-
L1 cells during adipogenesis. 3T3-L1 cells were fixed, permeablized and probed with a 
hyaluronan-binding protein during different stages of adipogenesis. To visualize internal HA, 3T3-
L1 cells were enzymatically pre-treated with 20 U/ml S. hyaluronidase (+SH) for 3 hours prior to 
fixation. The 3T3-L1 cells monolayer is depicted by phase contrast imaging in the first column. 
Low magnification images of HA staining in green and nuclear staining in blue are depicted in the 
middle column with a scale bar of 1000 nm. Higher magnification images of HA staining in green 




             
             
             
             
             










































             



















Figure 38. Detection of intracellular and extracellular hyaluronan (HA) associated with 3T3-
L1 cells treated with exogenous aggrecan during adipogenesis. Representative micrographs 
show 3T3-L1 cells 2, 4, 6, and 10 days after induction with adipogenesis media containing 2 mg/ml 
exogenous aggrecan. 3T3-L1 cells were fixed, permeablized and probed with a hyaluronan-
binding protein. To visualize internal HA, 3T3-L1 cells were enzymatically pre-treated with 20 
U/ml S. hyaluronidase (+SH) for 3 hours prior to fixation. The 3T3-L1 cells monolayer is depicted 
by phase contrast imaging in the first column. Low magnification images of HA staining in green 
and nuclear staining in blue are depicted in the middle column with a scale bar of 1000 nm. Higher 
magnification images of HA staining in green and nuclear staining in blue are depicted in the last 
column with a scale bar of 20 nm.
 
CHAPTER 4: DISCUSSION 
 
The goal of this dissertation was to gain insight into how hyaluronan-associated 
components of the extracellular/pericellular matrix participate in directing the differentiation fates 
of adult mesenchymal progenitor cells.  This work began with attempts to isolate and study a 
primary mesenchymal progenitor population from adult bovine articular cartilage and progressed 
to the use of the mesenchymal progenitor cell line, 3T3-L1. The goal of characterizing the 
differentiation of a progenitor cell found in adult cartilage to become an adipocyte, as well as a 
mature chondrocyte, changed to following the differentiation of an adipocyte-favoring progenitor 
cell line into a chondrocyte, as well as a mature adipocyte.  During adipogenesis, hyaluronan levels 
were observed to change dramatically.  Experimental manipulation of these changes delayed or 
blocked adipogenesis.  This study also demonstrates that the presence or absence of large 
proteoglycans, such as aggrecan or versican, may reflect the natural mechanism that cells/tissues 
use to control hyaluronan levels in vivo.  
 
Articular cartilage has limited intrinsic repair and renewal potential once damaged [9]. 
Surgical regeneration methods are available but either produce inferior fibrocartilage that is not 
able to withstand mechanical stress over time [238] or require healthy tissue for transplantation 
that can be difficult to obtain [52, 54].  A population of cells recently found in articular cartilage 
was shown to have progenitor characteristics such as a high colony formation capacity, 
mesenchymal stem cell markers, and acquisition of chondrogenic phenotype  after several passages 
[23, 24]. These specialized cells have been isolated based on enhanced binding to fibronectin and 
Hoechst   33342   dye  exclusion  [25, 26, 201, 239-241].  In  other  tissues, stem/progenitor  cells 
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provide a renewable source of cells capable of replacing damaged differentiated cells. This 
discovery opens the possibility of targeting a resident progenitor cell population within articular 
cartilage for not only repair, but regeneration of damaged cartilage with hyaline cartilage. Results 
found here confirm a small population of cells isolated from bovine articular cartilage that has a 
unique staining pattern with Hoechst 33342 dye consistent with the so-called side population 
[222]. Hoechst 33342 staining was selectively inhibited in the presence of the potent P-
glycoprotein inhibitor, verapamil, suggesting their dim Hoechst 33342 staining is due to the ABC-
binding cassette family of transporters. Expression of these transporters is a major determinant of 
the progenitor side population profile and has been shown to be important in maintaining 
progenitor cell stemness [242-244]. However, the percentage of cells comprising the side 
population was very low, an average of 0.15%, but similar to other studies [26]. This means that 
out of every 100,000 cells analyzed, only 150 cells would be available for analysis. To circumvent 
this issue, other researchers expanded the side populations in culture until appropriate numbers 
were obtained [26, 239]. However, primary chondrocytes dedifferentiate in 2-dimensional culture, 
changing their function, gene expression, and cell morphology to resemble fibroblasts or 
mesenchymal cells [191, 223, 245, 246]. To avoid creating mesenchymal like cells with expansion 
and dedifferentiation that could be confused with the side population, it was decided to forgo 
expansion and focus on enriching the side population.      
 
Studies have shown a greater number of progenitor cells reside in the superficial zones of 
articular cartilage compared to deeper zones [25, 26, 28] prompting an enrichment attempt by 
harvesting the superficial and middle/deep zones of the articular cartilage separately. However, 
there was only a modest increase in the side population of superficial cells detected compared to 
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deeper cells, 0.06% to 0.02%, respectively. Additionally, the ability to adhere to fibronectin 
through β1 receptors is also a stem cell characteristic that has been used to enrich mammalian 
progenitor cells from articular cartilage [25, 201, 247, 248]. In this dissertation, a portion of cells 
isolated from bovine articular cartilage adhered to fibronectin, however, we could not demonstrate 
any enhanced ability to efflux Hoechst 33342 dye in these cells through microscopic observation. 
Since attempts to increase the number of cells within the side population had failed, modifications 
of analyses were made in order to lower the number of cells needed.  
 
The most common differentiation pathways used to demonstrate multipotency of putative 
articular cartilage progenitor cells are osteogenesis, chondrogenesis, and adipogenesis [249, 250]. 
Three different cell lines were chosen as positive controls for these pathways to ensure 
differentiation could occur under optimal conditions. CH310T1/2, MG-63, and 3T3-L1 cells were 
selected for chondrogenic [251], osteogenic [252], and adipogenic [76] differentiation, 
respectively. Because articular cartilage is populated with chondrocytes and hypertrophic 
chondrocytes have been shown to differentiate into osteocytes during ossification [253, 254], 
articular cartilage-derived cells differentiated to become chondrocytes and/or osteocytes alone 
would not be a convincing demonstration of multipotency, therefore, adipogenesis was the main 
focus. 3T3-L1 cells were analyzed to determine that adipogenesis could be completed on a 
miniature scale using only a tenth of the cells normally required (104 cells per well compared to 
105). Unfortunately, while this was successful, it would still require more than 60 times the cells 
detected in 100,000 events per well. These cell numbers were just not feasible without expansion 
and expansion was undesirable. While we were able to confirm a side population of cells with a 
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unique Hoechst 33342 efflux profile that was isolated from bovine articular cartilage, we were 
unable to obtain enough side population progenitor cells for further analysis without expansion.  
 
A few exciting observations made while working with 3T3-L1 cells led to some novel 
findings. The first observation was that 3T3-L1 cells showed the highest Hoechst 33342 efflux 
potential when compared to the other differentiation control cell lines, suggesting they might have 
multipotent potential beyond their designated “pre-adipocyte, unipotent” status [69, 70]. This 
hypothesis was tested by determining their chondrogenic potential in micromass cultures when 
exposed to chondrogenic inducers. The second observation was that between days 4 and 6 during 
3T3-L1 adipogenic differentiation, aspirated medium was noticeably more viscous. This 
observation was originally made by Calvo et al. (1991) who identified hyaluronan as being partly 
responsible for the increase in viscosity [182]. Similarly, media conditioned by naked mole-rat 
fibroblasts were found to have increased viscosity after a few days of culture. When the media was 
tested, high-molecular mass hyaluronan was identified as the viscous substance [255]. Cell growth 
arrested by early contact inhibition is necessary for 3T3-L1 adipogenesis to occur [80] and Tian et 
al. established that hyaluronan was the extracellular signal that triggered the anticancer property 
of early contact inhibition found in naked mole-rat fibroblasts [255]. While a small handful of 
papers have addressed hyaluronan regulation during 3T3-L1 adipogenesis, how hyaluronan and 
its associated components as part of the pericellular matrix contribute to 3T3-L1 adipogenic 
differentiation remained unknown. We investigated the presence and properties of the pericellular 
matrix of mesenchymal 3T3-L1 and adipocyte 3T3-L1 cells in addition to the role of hyaluronan 




3T3-L1 cells were grown in micromass cultures and treated with and without chondrogenic 
inducers to test their multipotent ability. To the best of our knowledge, we are the first to report 
that 3T3-L1 cells possess chondrogenic potential. Three independent lines of experimental 
evidence support this conclusion. First, uniform alcian blue staining throughout revealed a drastic 
increase in sulfated proteoglycans when 3T3-L1 cells were grown in micromass culture with a 
chondrogenic medium. Second, analysis of mRNA showed the increased sulfated proteoglycan to 
be the chondrocyte and cartilage specific proteoglycan, aggrecan [256]. This increase in aggrecan 
expression was concomitant with a decrease in versican, the proteoglycan associated with rapidly 
proliferating cells [257, 258] and pre-cartilage mesenchymal condensations [153, 259, 260]. This 
observation is consistent with a previous report in avian limb buds where versican expression is 
lost in the cartilage core, where cells have developed a more rounded, chondrogenic phenotype 
and aggrecan is up-regulated [261]. Third, we report here that Has2 expression is significantly 
decreased in chondrogenic treated 3T3-L1 micormass cultures which is in agreement with previous 
studies that found Has2 expression to be decreased in pre-cartilage condensations [153, 262]. 
These findings are not perhaps too surprising considering the recent discovery of adipose derived 
stem cells and their chondrogenic potential [58, 263]. While more research needs to be completed 
to fully explore the chondrogenic potential of 3T3-L1 cells, having an additional chondrogenic 
model for an adipogenic to chondrogenic system that doesn’t involve an isolation step could aid 
in cartilage regeneration research.    
 
Midway through 3T3-L1 adipogenesis, the culture medium became noticeably more 
viscous. Long, mucoid strings were formed with a Pasteur pipette during aspiration (Figure 16). 
Calvo et al. made a similar observation in 1991 and identified an increase in hyaluronan in culture 
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medium (not cell-associated) by ion exchange chromatography as a likely contributor to the 
increase in viscosity [182]. Hyaluronan is a negatively charged, non-sulfated glycosaminoglycan 
that is a major component of the extracellular matrix in multiple tissues and is roughly 100 times 
more viscous than water at biological concentrations [264, 265]. In spite of its simple structure of 
repeating disaccharides, hyaluronan plays a key role in many crucial cellular processes including 
tissue remodeling (wound repair), inflammation, tumorigenesis, angiogenesis, proliferation, 
motility and differentiation [133, 266-268]. We analyzed culture media throughout adipogenesis 
with a modified ELISA to quantify hyaluronan concentrations and found a significant increase 
during mid-late adipogenesis. Media collected during mid-late adipogenesis contained nearly 4 
times the hyaluronan concentrations as media collected during early adipogenesis. This increase 
in hyaluronan is likely, at least, partially responsible for the increase in viscosity observed in 
conditioned media collected during mid-late adipogenesis, which is in agreement with findings 
from Calvo et al. [182].    
 
Hyaluronan is synthesized by three different transmembrane hyaluronan synthases, HAS1, 
HAS2, and HAS3 [120].  We and others have found HAS2 to be the primary synthase used to 
make hyaluronan in 3T3-L1 cells [184]. Hyaluronan is polymerized at the inner surface of the 
plasma membrane and then extruded through the membrane into the extracellular space where it 
is assembled in the extracellular matrix or anchored to the cell surface by the synthase or by 
binding a cell surface receptor [117]. Once anchored, hyaluronan contributes to the organization, 
structural integrity, and hydrodynamic properties of the pericellular matrix by acting as a scaffold 
on which other hyaladherins can assemble [155]. We found that one such hyaladherin, versican, 
displays less than half a fold increase upon adipogenic induction as shown by relative mRNA 
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levels then decreases steadily through late adipogenesis. A similar pattern was observed by us and 
others for Has2 expression [184].  This suggests that the increase in viscosity observed during 
mid-late adipogenesis is likely not due to an increase in versican or hyaluronan synthesis-but 
perhaps increased dissociation from the cell. This is in agreement with other studies that identified 
a “versican-like” chondroitin sulfate proteoglycan that interacted with hyaluronan in the culture 
medium of 3T3-L1 cells and was the same chondroitin sulfate proteoglycan that was mainly 
expressed in developing murine tissues [182, 183]. Versican has been shown to interact with 
endogenously produced hyaluronan via its G1 domain [269-271], similar to the articular cartilage 
proteoglycan, aggrecan [172, 272]. Both versican and aggrecan are capable of forming large 
aggregates of hyaluronan and link protein in the pericellular matrix of cultured cells [273].  
However, 3T3-L1 adipocytes no longer have the capacity for pericellular matrix assembly and thus 
are distinctly different from 3T3-L1 mesenchymal cells.  
 
 In addition to its structural properties, the binding of hyaluronan to the surface receptor, 
CD44, plays a critical role in cell-cell/matrix adhesive interactions and signal transduction that 
affect cytoskeletal association. Regulation of various genes associated with the formation of the 
extracellular matrix and cytoskeletal elements is required for adipogenesis to occur [274, 275] and 
this association could be partly responsible for the drastic changes observed in cell morphology 
and cytoskeletal components during adipocyte differentiation. CD44 is a broadly distributed single 
pass, transmembrane glycoprotein that is found on a variety of cell types [276]. To our knowledge, 
we are the first to report that Cd44 expression decreases after initial adipogenic induction and 
remains low throughout adipogenesis. CD44 anchors the pericellular matrix to the cell surface 
through its hyaluronan interactions, therefore its reduced expression could help explain why the 
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large pericellular matrices observed around mesenchymal 3T3-L1 cells are lost during 
differentiation to adipocytes. In addition, since hyaluronan internalization was detected 
concomitant with 3T3-L1 adipogenesis, CD44-mediated endocytosis of hyaluronan may be 
another mechanism to promote adipogenesis.   
 
3T3-L1 cells with mesenchymal morphology retained pericellular matrices and those with 
adipocyte morphology were unable to synthesize or retain one. We show that the pericellular 
matrix of mesenchymal 3T3-L1 cells can be removed by treatment with Streptomyces 
hyaluronidase and short hyaluronan oligosaccharides. CD44 has a high affinity for large 
hyaluronan molecules but exhibits competition for high molecular hyaluronan binding with a 
minimum of six hyaluronan sugar oligosaccharides (or three disaccharide units) in high 
concentrations [277].  These results suggest mesenchymal 3T3-L1 cells have high molecular 
weight hyaluronan-dependent pericellular matrices that are receptor anchored similar to those 
found on chondrocytes [278]. Exogenous aggrecan increased the pericellular matrix size of 
mesenchymal 3T3-L1 cells.  However, even when provided with exogenous hyaluronan and 
aggrecan, 3T3-L1 adipocytes were unable to assemble a detectable pericellular matrix (shown in 
Figure 19D). This most likely is partly due to the significant reduction in CD44 protein observed 
(Figure 18A) during late adipogenesis since CD44 serves as the critical link to the retention of 
hyaluronan-proteoglycan aggregates [279]. Similarly, COS-7 cells, which lack CD44, cannot 
assemble a pericellular matrix in the presence of exogenous aggrecan and/or hyaluronan until 




In this study, several components of the pericellular matrix show an initial increase in 
expression directly after exposure to adipogenic inducers and then taper off to a consistent level. 
This suggests that regulation of the pericellular matrix is necessary for adipogenic differentiation, 
particularly the early stages. This is further illustrated by the significant reduction in 3T3-L1 
adipogenesis when hyaluronan synthesis was inhibited with 4-MU treatment and with increased 
decoration of hyaluronan with exogenous aggrecan. While 4-MU interferes with the synthesis of 
hyaluronan, the addition of exogenous aggrecan increases the size of the pericellular matrix. Both 
treatments resulted in a relative increase in Has2, Cd44, and Vcan mRNA expression compared to 
untreated cultures. An alternative interpretation is that these treatments prevented the decreased 
expression of Has2 and Cd44 observed in untreated 3T3-L1 cultures during adipogenesis.  There 
are some reports that show 4-MU treatment decreases Has2 expression depending on the type of 
cells tested, but the results herein are consistent with studies performed in myofibroblasts [281, 
282]. Our results show that inhibiting (1) hyaluronan synthesis with 4-MU or (2) access to 
hyaluronan by increased decoration with exogenous aggrecan causes these pericellular 
components to be retained at close to pre-induction levels and significantly reduces the number of 
cells that successfully undergo adipogenesis. Of course in this study exogenous aggrecan is a 
surrogate hyaladherin for endogenous versican. Interestingly, even though Has2 levels were 
increased with exogenous aggrecan treatments (presumably causing an increase in hyaluronan 
synthesis), the viscosity of the culture medium remained unchanged.  One would expect the culture 
medium to remain unchanged by 4-MU treatment regardless of the increase in Has2 because 4-
MU inhibits the availability of monosaccharide substrate of the enzyme resulting in the inhibition 
of hyaluronan synthesis.  This suggests that any increase in hyaluronan synthesis is not being 
released into the culture medium and instead, is perhaps being retained at the cell surface as part 
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as the pericellular matrix. The increase in hyaluronan receptor, CD44, observed with exogenous 
aggrecan treatment supports this hypothesis because more receptors could bind more hyaluronan. 
With increased pericellular matrix components surrounding the cells, they are unable to efficiently 
undergo adipogenesis. These findings suggest hyaluronan released into the culture medium isn’t 
merely a product of adipogenesis, but may be a requirement of 3T3-L1 adipogenesis. This is 
similar to both chondrogenesis and myogenesis in which high levels of hyaluronan must be cleared 
from around the cell in order for cellular condensation and migration to occur and differentiation 
to proceed [165]. 
 
Treatment with 4-MU effectively inhibits hyaluronan synthesis and has been shown to 
completely block pericellular matrix assembly in murine primary chondrocytes [214]. If loss of 
the pericellular matrix is required for 3T3-L1 adipogenesis to occur, why would 4-MU treatment 
inhibit adipogenesis? Several studies have determined that hyaluronan modulates TGF-β1 
signaling to promote differentiation of myofibroblasts, although, they offer conflicting 
mechanisms as to how that modulation occurs [282, 283]. Webber et al. (2009) found that 
exogenous hyaluronan inhibited TGF-β1 signaling and suggested TGF-β1 required the synthesis 
of hyaluronan and not just its presence for proper signaling [283]. However, when Evanko et al. 
(2015) treated lung fibroblasts with 4-MU to inhibit hyaluronan synthesis, they observed an 
increase in myofibroblast differentiation [282]. Additionally, hyaluronan binding to CD44 led to 
a decrease in TGF-β1 mediated Smad signaling in renal epithelial cells while hyaluronan binding 
to CD44 led to an increase in TGF-β1 mediated Smad signaling in breast cancer cells [160, 284]. 
Different types of cells can have different responses to TGF-β1 which can be associated with 
differences in hyaluronan synthesis, turnover, different CD44 isoforms, and matrix integrity. 
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However, it has been reported that Smad3, which is activated by TGF-β through its receptor, binds 
to C/EBPβ to inhibit its transcriptional activity. This leads to a decrease in PPARγ transcription, a 
master regulator in adipogenesis, resulting in inhibition of adipocyte differentiation [90]. Knowing 
this, we propose the hypothesis that hyaluronan is required to initiate adipogenesis by binding to 
CD44, which binds TGF-β1 type I receptor, inhibiting the formation of TGF-β1 heterodimer 
receptor and its activation of Smad3, allowing transcription of early adipogenic genes (Figure 
39A). Reduction of cell-associated hyaluronan would be associated with Smad 3 phosphorylation, 
blocking induction of adipogenesis (Figure 39B).  
 
In addition to possible effects on TGF-β1, or other growth factor, signaling, adipogenesis 
may be modulated by the internalization of CD44 and hyaluronan. Cytoskeleton organization and 
organelle distribution are partially regulated by CD44 anchored to a hyaluronan dependent matrix 
[285]. This suggests that cytoskeleton-CD44-extracellular hyaluronan interactions might exert 
inside-out signaling, as suggested for chondrocytes [286]. The major method for hyaluronan 
elimination from the bloodstream by liver endothelial cells is by receptor-mediated endocytosis 
[287, 288]. Several studies found that CD44 facilitates a receptor-mediated uptake mechanism for 
hyaluronan internalization and degradation [150, 289]. In renal epithelial cells, hyaluronan bound 
to CD44 promotes TGF-β1 receptor trafficking to lipid rafts, which results in an increase in the 
association of TGF-β1 receptor with Smad7 [160]. Smad7 promotes receptor bound turnover 
located in lipid rafts via the caveolar internalization pathway. Endocytosis of cell surface receptors 
is an important regulatory event in signal transduction and this could partially explain the increase 
in intracellular hyaluronan in 3T3-L1 adipocytes and not mesenchymal cells. Allingham et al. 
(2006) showed expression of the hyaluronidase enzyme, Hyal2, was significantly increased during 
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adipogenesis in 3T3-L1 cells [184] and primarily localized in lysosomes [138]. Treatment with 
exogenous aggrecan causes the pericellular matrix to swell as aggrecan molecules fully decorate 
hyaluronan. The addition of exogenous aggrecan could block adipogenesis merely by steric 
hindrance. If highly aggrecan decorated hyaluronan cannot reach lysosomal HYAL2 through 
endocytosis, this may inhibit adipogenesis (Figure 40). Our lab has previously shown that 
hyaluronan highly decorated with exogenous aggrecan shows a significant reduction in 
endocytosis in rat chondrosarcoma cells [177]. It is unclear if the outcome of hyaluronan 
internalization is receptor turnover, internal hyaluronan signaling, or hyaluronan degradation but 
the inhibition of adipogenesis with exogenous aggrecan suggest access to hyaluronan for 
binding/cleaving and internalization is essential for adipogenesis to occur. 
 
   The control of cell shape, migration, proliferation, differentiation, and tissue 
development is regulated by the composition of the pericellular matrix, with adipocytes being no 
exception [290, 291]. Despite the recent growth of information regarding the effects of pericellular 
and extracellular components on adipogenesis, many questions still remain, and continued research 
is required to build and refine our current knowledge. However, our novel observations that the 
pericellular matrix and CD44 expression is lost during adipogenesis, and that blocking hyaluronan 
synthesis or increasing decoration of hyaluronan with exogenous aggrecan during the adipogenic 
differentiation protocol effectively inhibits 3T3-L1 adipogenesis further highlight the importance 
of the hyaluronan-dependent pericellular matrix in controlling adipocyte formation. Even though 
the clinical importance of these findings are not immediately evident, details of how the 
pericellular matrix is assembled and disassembled during adipogenesis could prove facilitative for 











Figure 39.  Hyaluronan is required for initiation of adipogenesis.  CD44 occupied with 
hyaluronan has increased affinity for TGF-β receptor type I [160]. CD44 associates with TGF-β 
receptor type I disassembling the heterodimer with TGF-β receptor type II resulting in the inability 
to bind its ligand [292]. Without ligand binding, Smad3 is not phosphorylated nor does it 
translocate to the nucleus as part of the Smad complex to block transcription of early adipogenesis 
genes (A). When hyaluronan synthesis is blocked with 4-MU treatment, there is little to no 
hyaluronan to bind CD44. The TGF-β receptor heterodimer is able to bind its ligand and 
phosphorylate Smad3. Active Smad3 associates with other Smad proteins and translocates to the 















Figure 40. Exogenous aggrecan inhibits CD44-mediated endocytosis required for 
adipogenesis. CD44 bound to hyaluronan lightly decorated with native versican clusters in lipid 
rafts. Caveolin protein binds to the lipid raft containing the cluster of CD44 and invaginates the 
membrane [161]. The lightly decorated hyaluronan is able to be surrounded by the invaginating 
membrane to form an endosomal vesicle that can be transported to a lysosome for degradation of 
the cargo (A).  The addition of exogenous aggrecan fully decorates hyaluronan chains. These 
highly decorated hyaluronan chains prevent lipid raft clusters of CD44 from undergoing 
endocytosis likely due to steric hindrance based on the significant increase in volume of the 
additional aggrecan bound to hyaluronan. Without endocytosis of CD44 for both receptor 
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